28.04.2013 Views

Kalabhavi Srinivas K.pdf

Kalabhavi Srinivas K.pdf

Kalabhavi Srinivas K.pdf

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL COMPARING<br />

OPEN PYELOPLASTY AND LAPAROSCOPIC PYELOPLASTY IN THE<br />

TREATMENT OF PRIMARY URETEROPELVIC JUNCTION (UPJ)<br />

OBSTRUCTION AT KLES HOSPITAL & MRC, BELGAUM FOR A PERIOD<br />

OF 1 YEAR FROM APRIL 2004 TO MARCH 2005<br />

Submitted by :<br />

DR. SRINIVAS. K. KALABHAVI<br />

DISSERTATION<br />

Submitted to the<br />

Rajiv Gandhi University of Health Sciences, Karnataka,<br />

Bangalore.<br />

In partial fulfillment<br />

of the requirements for the award of the degree of<br />

M.S IN GENERAL SURGERY<br />

Under the Guidance of :<br />

DR. I. V. UPPIN MS<br />

Associate Professor<br />

DEPARTMENT OF GENERAL SURGERY<br />

J. N. MEDICAL COLLEGE,<br />

BELGAUM-590010. KARNATAKA.<br />

APRIL 2006<br />

I


RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES,<br />

KARNATAKA, BANGALORE.<br />

Declaration By The Candidate<br />

I hereby declare that this thesis entitled “A<br />

PROSPECTIVE RANDOMIZED CONTROLLED TRIAL COMPARING OPEN<br />

PYELOPLASTY AND LAPAROSCOPIC PYELOPLASTY IN THE TREATMENT OF<br />

PRIMARY URETEROPELVIC JUNCTION (UPJ) OBSTRUCTION AT KLES<br />

HOSPITAL & MRC, BELGAUM FOR A PERIOD OF 1 YEAR FROM APRIL 2004<br />

TO MARCH 2005” is a bonafide and genuine research work carried<br />

out by me under the guidance of DR. I. V. UPPIN MS. Associate<br />

Professor, Department of General Surgery. J. N. Medical College,<br />

Belgaum.<br />

Date : DR. SRINIVAS. K. KALABHAVI<br />

Place : Belgaum Department of General Surgery,<br />

J. N. Medical College,<br />

Belgaum - 590 010.<br />

II


RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES,<br />

KARNATAKA, BANGALORE.<br />

Certificate By The Guide<br />

This is to certify that the thesis entitled “A PROSPECTIVE<br />

RANDOMIZED CONTROLLED TRIAL COMPARING OPEN PYELOPLASTY AND<br />

LAPAROSCOPIC PYELOPLASTY IN THE TREATMENT OF PRIMARY<br />

URETEROPELVIC JUNCTION (UPJ) OBSTRUCTION AT KLES HOSPITAL & MRC,<br />

BELGAUM FOR A PERIOD OF 1 YEAR FROM APRIL 2004 TO MARCH 2005”<br />

is a bonafide research work done by DR. SRINIVAS. K.<br />

KALABHAVI in partial fulfillment of the requirement for the<br />

Degree of Masters of Surgery in General Surgery.<br />

Co-Guide Guide<br />

Dr. R. B. Nerli MS MCh (Urology) Dr. I. V. Uppin MS<br />

Professor & Head, Associate Professor<br />

Department of Urology, Department of General Surgery,<br />

J. N. Medical College, J. N. Medical College,<br />

Belgaum – 590 010. Belgaum – 590 010.<br />

Karnataka. Karnataka.<br />

Date :<br />

Place : Belgaum<br />

III


RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES,<br />

KARNATAKA, BANGALORE.<br />

Endorsement By Head Of The Department,<br />

Principal/Head Of The Institution<br />

This is to certify that the thesis entitled “A PROSPECTIVE<br />

RANDOMIZED CONTROLLED TRIAL COMPARING OPEN PYELOPLASTY<br />

AND LAPAROSCOPIC PYELOPLASTY IN THE TREATMENT OF PRIMARY<br />

URETEROPELVIC JUNCTION (UPJ) OBSTRUCTION AT KLES HOSPITAL &<br />

MRC, BELGAUM FOR A PERIOD OF 1 YEAR FROM APRIL 2004 TO<br />

MARCH 2005” is a bonafide research work done by DR.<br />

SRINIVAS. K. KALABHAVI under the guidance of<br />

DR. I. V. Uppin MS Associate Professor Department of<br />

General Surgery, J. N. Medical College, Belgaum.<br />

DR. A. S. GODHI. M.S.,F.I.C.S DR. V. D. PATIL. MD. (Paed)<br />

Professor & Head, Principal,<br />

Department of General Surgery, J. N. Medical College,<br />

J. N. Medical College, Belgaum – 590 010.<br />

Belgaum. Karnataka. Karnataka.<br />

IV


RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES,<br />

KARNATAKA, BANGALORE.<br />

COPYRIGHT<br />

Declaration By The Candidate<br />

I hereby declare that Rajiv Gandhi University of<br />

Health Sciences, Karnataka, Bangalore, shall have the<br />

rights to preserve, use and disseminate this thesis in print<br />

or electronic format for academic / research purpose.<br />

Date : DR. SRINIVAS. K. KALABHAVI<br />

Place : Belgaum. Department of General Surgery,<br />

J. N. Medical College,<br />

Belgaum - 590 010.<br />

© Rajiv Gandhi University of Health Sciences, Karnataka,<br />

Bangalore.<br />

V


Acknowledgement<br />

I express my deep sense of gratitude to Professor of Surgery<br />

and my guide Dr. I. V. Uppin MS and Co-Guide Dr. R. B. Nerli MS MCh<br />

(Urology) whose guidance and encouragement all throughout their<br />

periodic assessment and specific corrections, coupled with their<br />

rich knowledge and keen interest in the topic, was my constant<br />

source of inspiration leading to the success of this study.<br />

I would like to take this opportunity to express my most<br />

sincere and humble gratitude to Dr. A. S. Godhi M.S.,F.I.C.S, Professor<br />

and Head of Department of Surgery, J. N. Medical College,<br />

Belgaum for his guidance, continuous supervision and critical<br />

review of this work at regular “thesis meetings.”<br />

I express my deep sense of gratitude to Dr. S. M. Uppin M.S., F.I.C.S<br />

Professor of Surgery, Dr. S. S. Shimikore M.S. Professor of Surgery,<br />

Dr. M. S. Sangolli M.S. Professor of Surgery, Dr. V. M. Uppin M.S.,<br />

Professor of Surgery, Dr. A. C. Pangi M.S., Associate Professor of<br />

surgery, Dr. A. S. Gogate M.S., Assistant Professor of Surgery, Dr.<br />

Sanjay Karpoor M.S., Lecturer of Surgery for their encouragement,<br />

valuable guidance and moral support throughout the course of this<br />

study.<br />

I humbly recognize the courtesy of Dr. V. B. Dhaded M.S.,F.I.C.S,<br />

Professor of Surgery, Dr. P. S. Pattanshetti M.S., Associate Professor<br />

of Surgery, Dr. R. R. RaoM.S., Assistant Professor of Surgery,<br />

Dr. S.T.Vedbhushan M.S., Lecturer of Surgery on whom I have made<br />

demands of one kind or another and their response has energized<br />

the realization of this dissertation.<br />

VI


I shall also remain grateful to Dr. B. V. Gogeri M.S.,F.R.C.S.,<br />

Associate Professor of Surgery, Dr. S. C. Metgud M.S., Assistant<br />

Professor of Surgery, Dr. A. P. Bellad M.S., Assistant Professor of<br />

Surgery for their valuable suggestions during the preparation of<br />

this dissertation.<br />

I am also thankful to Dr. Mallikarjuna Reddy M.S.,M.Ch (Urol)<br />

Associate Professor, Dr. S. I. Neeli M.S. M.Ch (Urol) Associate<br />

Professor, Dr. Abhinandan S. M.S M.Ch (Urol) Associate Professor, Dr.<br />

Vinay Patil M.S M.Ch (Urol) Associate Professor, Dr. Shailesh A. M.S (M.Ch)<br />

registrar in urology and Dr. I. R. Ravish, M.S (M.Ch) registrar in urology.<br />

I am also thankful to Dr. S. Patil, M.S. Lecturer and Dr.<br />

<strong>Srinivas</strong>rao M.S. Lecturer, Dr. Basavaraj K. M.S Lecturer for their<br />

guidance.<br />

I am grateful to Dr. V. D. Patil M.D.,D.C.H., Principal of J. N.<br />

Medical College, Belgaum for allowing me to undertake this study.<br />

I express my sincere thanks to Medical Director of K.L.E.S.<br />

Hospital and MRC and the District Surgeon, Civil Hospital,<br />

Belgaum for allowing me to utilize the facilities to undertake this<br />

study.<br />

I offer my sincere thanks to my colleagues and friends<br />

Dr. Kantesh, Dr. Rohan Thakkar, Dr. Ramesh, Dr. Ramya, Dr.<br />

Gagan & Dr. Prashant for their valuable help in completing this<br />

study.<br />

I am grateful to my mother & other family members for their<br />

constant inspiration, encouragement and moral support.<br />

I am grateful to Mr. Dhareshwar for his valuable suggestions<br />

in statistical analysis of my dissertation.<br />

Most importantly I thank the backbone of my study, my<br />

patients for their cooperation and willing participation in the study.<br />

VII


I am also thankful to Mr. Satish, Ms. Rajeshwari, Mr. Kaleem &<br />

Mr. Shripad of Sheegra Designing & Printing Solutions for their excellent<br />

typographic work.<br />

VIII<br />

Dr. <strong>Srinivas</strong> K. <strong>Kalabhavi</strong>


LIST OF CONTENTS<br />

S. No Topic Page No<br />

1 Introduction 1<br />

2 Aims and objectives 3<br />

3 Review of literature 4<br />

4 Materials & Methods 57<br />

5 Observations & Results 80<br />

6 Discussion 93<br />

7 Summary & Conclusion 101<br />

8 Bibliography 105<br />

9 Annexures<br />

Master Chart 112<br />

Proforma 114<br />

IX


Figure<br />

No.<br />

LIST OF FIGURES<br />

Topic Page No<br />

1 Arterial blood supply to the ureter 11<br />

2 A lower pole-crossing vessel causing UPJO 11<br />

3 Dismembered pyeloplasty 32<br />

4 Dismembered pyeloplasty in a large or redundant<br />

renal pelvis<br />

5 Dismembered pyeloplasty in aberrant or accessory<br />

lower pole vessels<br />

6 Foley Y-V plasty 37<br />

7 Culp-Deweerd spiral flap 38<br />

8 Scardino-prince vertical flap 39<br />

9 Intubated ureterotomy 41<br />

10 Prenatal diagnosis of HN 56<br />

11 Pictoral analog pain scale 79<br />

X<br />

32<br />

33


LIST OF TABLES<br />

Table No. Topic Page No<br />

1 Sex Incidence 80<br />

2 Laterality 81<br />

3 Age distribution 81<br />

4 Symptoms 83<br />

5 Associated anomalies 83<br />

6 Postoperative complications 85<br />

7 Renal function on renal scientigraphy<br />

(GFR/min) in open pyeloplasty group<br />

(n=15)<br />

8 Renal function on renal scientigraphy<br />

(GFR/min) in laparoscopic pyeloplasty<br />

group (n=15)<br />

9 Preoperative and postoperative<br />

pyeloplasty analog pain and activity<br />

scores<br />

10 Assessment of objective outcome 92<br />

XI<br />

87<br />

89<br />

91


XII


LIST OF GRAPHS<br />

Graph No. Topic Page No<br />

1 Sex Incidence 82<br />

2 Laterality 82<br />

3 Symptoms 84<br />

4 Postoperative complications 86<br />

5 Renal function on renal scientigraphy<br />

(GFR ml/min) in open pyeloplasty<br />

group (n=15)<br />

6 Renal function on renal scientigraphy<br />

(GFR ml/min) in laparoscopic<br />

pyeloplasty group (n=15)<br />

XIII<br />

88<br />

90


LIST OF PHOTOGRAPHS<br />

S. NO Topic Page No<br />

1 IVP 20<br />

2 Renal USG 22<br />

3 CT scan of KUB 22<br />

4 M.R. Urogram 23<br />

5 Renal scientigraphy with Tc-99m DTPA scan 25<br />

6 Position of the patient 60<br />

7 Open pyeloplasty procedure : Dissection of<br />

8<br />

9<br />

obstructed upj in left kidney<br />

Traction on proximal ureter before<br />

dismembering the dilated pelvis<br />

Dismembered ANDERSON-HYNES<br />

pyeloplasty<br />

being performed<br />

10 Anastomosis of proximal ureter to the redundan<br />

pelvis in a watertight fashion<br />

11 Completed anterior anastomosis 66<br />

12 Completed posterior anastomosis 66<br />

13<br />

Incision wound after the procedure with drain<br />

seen<br />

14 Excised narrowed proximal ureter 67<br />

15 Laparoscopic instruments 70<br />

XIV<br />

64<br />

64<br />

65<br />

65<br />

67


16 Insertion of trocar and laparoscopes 71<br />

17 Showing enlarged pelvis due to PUJO 71<br />

XV


LIST OF PHOTOGRAPHS<br />

XVI<br />

Contd…<br />

S. NO Topic Page No<br />

18 Pelvis being opened with guidewire being<br />

seen<br />

19 Reconstruction of UPJ 72<br />

20 Reconstruction of UPJ being completed 73<br />

21 Completed laparoscopic pyeloplasty with a<br />

drain through one of the port site<br />

22 Preoperative renal scientigraphy showing<br />

reduced renal function in the left kidney<br />

23 Postoperative renal scientigraphy showing<br />

24<br />

improved renal function in the left kidney<br />

Showing postoperative scar after 3 months in<br />

open and laparoscopic pyeloplasty done in a<br />

same patient who had bilateral PUJO<br />

72<br />

73<br />

75<br />

75<br />

76


INTRODUCTION<br />

Proforma<br />

Many treatment options exist for the management of UPJ obstruction. Open<br />

pyeloplasty has high success rate & has been considered the gold standard. But there<br />

is a significant postoperative pain & long recovery time in open pyeloplasty<br />

surgeries. In an attempt to minimize the post-operative morbidity of open surgical<br />

UPJ correction many minimally invasive options have been developed. These include<br />

balloon dilation, antegrade endopyelotomy, retrograde endopyelotomy, Acucise<br />

endopyelotomy and Laparoscopic pyeloplasty 1 .<br />

During last decade, advances in endourological techniques have resulted in<br />

significant progress in the development of minimally invasive surgical procedures to<br />

treat UPJ obstruction. UPJ is the most common site of upper urinary tract obstruction<br />

occurring in 1 in 1500 births. The historical aspects of UPJ repair were reviewed by<br />

Kay in 1989 & Schaeffer & Grayhack in 1986. The first reconstructive procedure<br />

was performed by Trendelenberg in 1886, although patient died of postoperative<br />

complications. Kuster is credited with the first successful open pyeloplasty (1891). In<br />

1892 Frenzer, applied the Heineke-Mikulitz principle for reconstruction of the UPJ 2 .<br />

Flap techniques were introduced by Schwyer in 1916. His Y-V pyeloplasty<br />

was then modified successfully by Foley in 1937. Spiral flap of Culp DeWeerd<br />

(1951), the vertical flap of Scardino & Prince (1953), Thompson & colleagues (1969)<br />

renal capsular flaps developed later in 1949. Anderson & Hynes, two English<br />

surgeons described their modification of Kusters dismembered procedure that<br />

involved anastomosis of the spatulated ureter to a projection of the lower aspect of<br />

the pelvis after a redundant portion was excised 2 .


Proforma<br />

The techniques of intubated ureterotomy were popularized by Davis in 1943,<br />

but they had been previously described by Fiori in 1905, Albarran in 1909 and Keyes<br />

in 1915 2 . Laparoscopic pyeloplasty was first reported in 1993 both by Schuessler and<br />

co-workers and by Kavoussi and Peters, who utilized dismembered pyeloplasty<br />

technique. During last decade, advances in endourological techniques have resulted<br />

in significant progress in the development of minimally invasive surgical procedures<br />

to treat UPJ obstruction. The combination of less postoperative morbidity, improved<br />

cosmesis, shorter convalescence and comparable operative success rates has lured<br />

many patients away from gold standard of open pyeloplasty. Only few retrospective<br />

studies have been conducted regarding laparoscopic versus open pyeloplasty. Success<br />

rates are comparable for laparoscopic pyeloplasty and open pyeloplasty 3 .


AIMS AND OBJECTIVES<br />

Proforma<br />

To compare the efficacy of laparoscopic pyeloplasty versus open pyeloplasty<br />

in the treatment of primary UPJ obstruction with respect to the SUBJECTIVE<br />

OUTCOME (Postoperative pain, activity level, time when oral feeds are started) and<br />

OBJECTIVE OUTCOME (success rate, complications, improvement in renal<br />

function, operative time, recovery time/hospital stay, cost of the treatment and<br />

cosmesis).


Historical notes 26, 27 :<br />

REVIEW OF LITERATURE<br />

Proforma<br />

The term hydronephrosis was introduced by Rayer in 1841. He described a<br />

patient with hydronephrosis caused by reduplication of the ureter with folds and<br />

contractions at the level of the ureteropelvic junction. Bonetus in 1679, described a<br />

child with a hydronephrotic kidney in whom the ureter was merely a fibrous cord..<br />

Gustave Simon in 1869 performed the first deliberate (and successful) nephrectomy<br />

and showed conclusively that a kidney could be removed without permanent<br />

impairment to the health of the individual. This event is notable because it paved the<br />

way for renal surgery.<br />

In the late 1800s, surgeons began conserving renal tissue rather than<br />

proceeding directly to nephrectomy. The first reported attempt at surgical repair of<br />

hydronephrosis is credited to Trendelenburg in 1886. He used an abdominal<br />

approach, which resulted in a colonic injury, and the patient died shortly after<br />

surgery. The case was not reported until 4 years later. Kuster is credited with the first<br />

successful procedure for the relief of hydronephrosis performed on June 14, 1891.<br />

The patient was a 13-year-old boy with a solitary kidney who had previously<br />

undergone a nephrostomy, which would not close. Kuster found the upper ureter to<br />

be entirely obliterated, resected the obliterated tissue, and anastomosed the ureter into<br />

the most dependent portion of the renal pelvis. The operation was successful and<br />

stimulated great interest in the repair of hydronephrosis. Kuster reported his case to<br />

the 21st German Surgical Congress on June 8, 1892. At that time, Trendelenburg<br />

described his case and endorsed the concept of conservative surgery for<br />

hydronephrosis. Christian Fenger of Chicago, unaware of Kuster's work, simultane-


Proforma<br />

ously and independently surgically corrected UPJ obstruction using the Heineke-<br />

Mikulicz principle. Fenger has been given credit for introducing conservative renal<br />

surgery in the United States. By 1899, he had reported seven cases; four patients<br />

were clinically relieved and free of symptoms and three cases failed, requiring<br />

nephrectomy.<br />

Conservative renal surgery for the relief of hydronephrosis was considered so<br />

important that it was the main topic of discussion at the 13th International Congress<br />

of Medicine in Paris in 1900. Five papers were delivered by pioneers in the field:<br />

Kuster, Fenger, Bazy, Albarran, and Legueu. As operations to correct hydronephrosis<br />

became more widely performed, comparisons of primary nephrectomy versus<br />

pyeloplasty were published. In 1903, primary nephrectomy had an 80% cure rate but<br />

a 20% mortality rate. Pyeloplasty had a 37% cure rate and a 10% mortality rate.<br />

Some surgeons, led by Pasteau, were convinced that hydronephrosis was the<br />

result of a movable kidney resulting in obstruction of the ureter by anomalous blood<br />

vessels, adhesive bands, or torsion of the ureter. Their preferred surgical approach<br />

involved nephropexy and lysis of these bands. Others believed that hydronephrosis<br />

was caused by constriction of the upper ureter and was best corrected by pyeloplasty.<br />

In 1921, von Lichtenberg described a technique for pyeloureteroplasty in which an<br />

inverted U-shaped incision was made in the adjacent walls of the renal pelvis and<br />

ureter through the obstructed UPJ. The anterior and posterior edges of the pelvis and<br />

ureter were then sutured together. In 1923, Schwyzer described a technique for<br />

correcting UPJ obstruction, based on principles of pyloroplasty in which the ureter<br />

was first freed of adhesive bands. A. Y-shaped incision was then made, extending<br />

from the renal pelvis to the ureter. The flap was pulled down into the split ureter and<br />

sutured in place, forming a "V." Resection of the redundant renal pelvis and


Proforma<br />

nephrostomy drainage was introduced in the late 1920s by Papin and Walters. In<br />

1937, Foley modified Schwyzer's Y procedure by extending the upper limbs of the Y<br />

onto the posterior and anterior walls of the renal pelvis. The lower limb of the Y was<br />

extended down the lateral aspect of the ureter. In 1943, Davis described intubated<br />

ureterotomy in which a longitudinal incision is made in the narrowed portion of the<br />

ureter; a tube is left in place for 6 weeks until the ureter regenerates around the tube.<br />

In 1949, Anderson and Hynes described dismembered pyeloplasty (although it was<br />

the method used by Kuster almost 60 years earlier). Their objectives were to excise<br />

the obstructing lesion, resect the redundant pelvis if necessary, and place a dependent<br />

flap of renal-pelvic tissue into the split ureter. Maintenance of ureteral continuity was<br />

considered important by many, and in 1951 and 1953 flap pyeloplasties were<br />

described by Culp and Scardino, respectively. However, as favorable results with the<br />

dismembered pyeloplasties accumulated, it became clear that maintenance of ureteral<br />

continuity was not essential to success and the flap and intubated procedures were<br />

relegated to secondary roles for the treatment of long ureteral strictures.<br />

Laparoscopic pyeloplasty was first performed by Schuessler 60 and coworkers<br />

in 1993 on 5 patients with a mean follow up of 12 months. Recker and associates in<br />

1995 reported an early European experience in 5 patients. Janetschek and colleagues<br />

in 1996 reported their results in Austria with both retroperitoneoscopic and<br />

laparoscopic approaches to both dismembered and non-dismembered pyeloplasty.<br />

Chen and coworkers in 1998 reported laparoscopic pyeloplasty in 44 patients. Baeur<br />

and his associates in 1999 performed a comparative study of the objective and<br />

subjective outcomes of the laparoscopic versus open pyeloplasty in a multicentre<br />

review.


Proforma<br />

Although a variety of procedures have been described for management of the<br />

obstructed UPJ, several basic principles must always be applied to ensure successful<br />

repair. For any technique, the resultant anastomosis should be widely patent and<br />

performed in a watertight fashion without tension. Finally, the reconstructed UPJ<br />

should allow a funnel-shaped transition between the pelvis and the ureter that is in a<br />

position of dependent drainage.


Proforma<br />

URETEROROPELVIC JUNCTION OBSTRUCTION (UPJ OBSTRUCTION)<br />

UPJ obstruction may be defined as a functional or anatomic obstruction to<br />

urine flow from the renal pelvis to proximal ureter that results in symptoms or renal<br />

damage 4 .<br />

Hydronephrosis caused by clinically significant obstruction at the UPJ is a<br />

well-known and commonly encountered condition in infants and children.<br />

Historically, it is known that 50% of all abdominal masses in infants are of renal<br />

origin, and of these renal masses, 40% are from UPJ obstruction with resultant<br />

hydronephrosis (HN). The UPJ is the most common site of urinary tract obstruction,<br />

occurring in l in 1500 births 2 . With early recognition and institution of properly timed<br />

surgical correction, the majority of these kidneys can be predicted to remain<br />

asymptomatic and contribute significantly to the total renal function of the patient.<br />

However, failure of timely recognition and treatment often results in destruction of<br />

the involved renal unit, and nephrectomy is ultimately required 5 .<br />

UPJ obstruction occurs in all age groups, from intra-uterine life to old age, but<br />

there tends to be a clustering in the neonatal period because of the detection of<br />

antenatal HN and again later in life because of symptomatic occurance. UPJ<br />

obstruction occurs more commonly in boys than girls in the newborn period, when<br />

the ratio exceeds 2:1 6 , left sided lesions predominate (approx. 67%) and bilateral UPJ<br />

obstruction is present in 10-40% of cases 7 .<br />

Embryology:


Proforma<br />

The UPJ is formed during the 5 th week of embryogenesis. The collecting<br />

system of the kidney develops from the ureteric bud, which contacts and penetrates a<br />

cap of metanephric blastema 8 . The ureteric bud dilates, forming a primitive renal<br />

pelvis. The primitive renal pelvis splits into a cranial and caudal portion, forming the<br />

future major calices. Each major calyx continues to divide and further penetrate the<br />

metanephric blastema. There will be 12 or more such divisions, continuing until the<br />

end of the 5 th month of gestation, when the 2 nd generation tubules enlarge and absorb<br />

the tubules of the 3 rd and 4 th divisions, resulting in the formation of the minor calices.<br />

The 5 th and successive generations converge on the minor calices and form the renal<br />

pyramids. The ureteric bud thus gives rise to the ureter, renal pelvis, major and<br />

minor calices, and 1-3 million collecting ducts 5 . By the 10 th week of embryogenesis,<br />

urine is formed and can pass from the glomeruli to the bladder 9 .<br />

Histology:<br />

The renal pelvis is composed of 3 layers: mucosa, muscularis and adventitia.<br />

The inner layer is mucosa and is lined by transitional epithelium supported by a<br />

lamina propria. The epithelium is 2-3 cells thick in the renal pelvis and 4-5 cells thick<br />

in the ureter. The epithelium sits on a thin basal lamina, which rests on the lamina<br />

propria composed of dense fibroconnective tissue with prominent elastic fibres. In<br />

transverse section, the ureteral lumen appears stellate as a result of the folds of<br />

mucosa resulting from the looseness of the lamina propria, the elastic fibres and the<br />

muscularis. The muscularis is composed of interdigitating fibres of smooth muscles<br />

separated by strands of connective tissue. These muscle fibers are arranged into an<br />

inner longitudinal layer and an outer circular layer. The adventitia is external to the


Proforma<br />

muscular layer and is composed of fibroelastic tissue, which is continuous with the<br />

capsule of the kidney 10 .<br />

Blood supply 3 :<br />

In an adult, the ureter is generally 22 to 30 cms in total length, varying with<br />

body size and habitus. Its origin at UPJ is often vaguely defined in the normal state.<br />

The ureter receives its blood supply from multiple feeding arterial branches along its<br />

course. In the retroperitoneum, the ureter may receive branches from renal artery,<br />

gonadal artery, abdominal aorta & common iliac artery. After entering the pelvis,<br />

additional small branches to the distal ureter may arise from the internal iliac artery<br />

or its branches, especially vesical and uterine arteries, but also from the middle rectal<br />

and vaginal arteries. Arterial branches to the upper ureter approach from the medial<br />

direction, whereas arterial branches within pelvis approach the ureter from a lateral<br />

direction. After reaching the ureter, the arterial vessels course along longitudinally<br />

within the periarterial adventitia in an extensive anatomising plexus. The venous and<br />

lymphatic drainage of the ureter generally parallels the arterial supply.<br />

The normal ureter is not of uniform caliber with 3 distinct narrowing along its<br />

course. The first is at UPJ, second region of narrowing occurs as the ureter crosses<br />

the iliac vessels and the third site is at uretero vesical junction.<br />

1


Renal<br />

Gonadal<br />

Aortic<br />

Common, iliac<br />

Internal iliac<br />

Uterine<br />

Middle rectal<br />

Vaginal<br />

FIG No. 1 : ARTERIAL BLOOD SUPPLY TO THE URETER<br />

Lower pole crossing vessel<br />

Superior vesical<br />

Inferior vesical<br />

Proforma<br />

FIG No. 2 : A LOWER POLE-CROSSING VESSEL CAUSING UPJO


Nerve supply 3 :<br />

Proforma<br />

The ureters receive preganglionic sympathetic input from T10-L2 spinal<br />

segments. Postganglionic fibres arise from several ganglia in the aorticorenal,<br />

superior and inferior hypogasrtic autonomic plexuses. Parasympathetic input is from<br />

S2-S4 spinal segments. Exact role of ureteral neural input is unclear. Normal ureteral<br />

peristalsis does not require autonomic input but, rather, originates and is propagated<br />

from intrinsic smooth muscle pacemaker sites located in the minor calyces of the<br />

renal collecting system. The autonomic nervous system may exert some modulating<br />

effect on this process.<br />

Pain Perception and Somatic Referral 3 :<br />

The pain fibres leave the kidney, renal pelvis, and ureter, travelling with the<br />

sympathetic nerves. They are primarily stimulated by nociceptors sensitive to<br />

increased tension (distention) in the renal capsule, renal collecting system, or ureter.<br />

The resulting visceral pain is felt directly and is referred to somatic distributions that<br />

correspond to the spinal segments providing the sympathetic distribution to the<br />

kidney and ureter (eighth thoracic through second lumbar). Pain and reflex muscle<br />

spasm are typically produced over the distributions of the subcostal, iliohypogastric,<br />

ilioinguinal, and /or genitofemoral nerves, resulting in flank, groin, or scrotal (or<br />

labial) pain and hyperasthesia, depending on the location of the noxious visceral<br />

stimulus.


Physiology:<br />

Proforma<br />

The origin of electrical activity for ureteral peristalsis begins at pace maker<br />

sites located in the proximal portion of the collecting system. Muscular contractions<br />

occur within the calices and renal pelvis more frequently than in the upper ureter.<br />

Hence, the renal pelvis fills, producing a rise in the renal pelvic pressure. A bolus of<br />

urine is then delivered from the pelvis into the upper ureter, after which ureteral<br />

contractions move the bolus down the ureter. The UPJ remains closed during these<br />

ureteral contractions to prevent flow of urine back into the renal pelvis. Two to six<br />

ureteral peristaltic contractions occur per minute and are propelled at a rate of 2-6<br />

cms/second. Efficient transport of urine is dependent on coaptation of the pelvis and<br />

ureteral walls. Resting baseline intraureteral and intrapelvic pressures range from 0-5<br />

cm H2O. Ureteral pressures during a contraction range from 20-60 cm H2O. As the<br />

volume of urine increases, there is a 1:1 correlation between conduction of caliceal<br />

contractions and ureteral contractions 11 .<br />

Etiology:<br />

The precise cause of UPJ obstruction remains elusive. A narrowing of the<br />

UPJ is often found, but whether this is a result of developmental arrest or of<br />

incomplete recanalization of the ureter is not yet known 12 .<br />

The causes of UPJ obstruction can be divided into 2 types.<br />

1. Primary or congenital UPJ obstruction.<br />

Intrinsic causes.<br />

Extrinsic causes.<br />

2. Secondary or acquired UPJ obstruction.


I. Primary or congenital UPJ obstruction:<br />

1. Intrinsic causes:<br />

Congenital obstruction most often results from intrinsic disease.<br />

Proforma<br />

a. A frequently found defect is the presence of an aperistaltic segment of the ureter.<br />

In these cases, histopathologic studies reveal that the spiral musculature normally<br />

present has been replaced by abnormal longitudinal muscle bundles or fibrous<br />

tissue 13 . Further work has shown that the expression of transforming growth<br />

factor β (TGF-β) is increased in the pelvis of partially obstructed kidneys 14 .<br />

This results in failure to develop a normal peristaltic wave for propagation of<br />

urine from the renal pelvis to the ureter. Such ureter may appear grossly normal<br />

at the time of surgery, and in fact, may often be calibrated to No.14 Fr or greater.<br />

b. A less frequent intrinsic cause of congenital UPJ obstruction is true ureteral<br />

stricture. These are most frequently found at the UPJ, although they may be<br />

located at sites anywhere along the ureter. Electron microscopy has demonstrated<br />

excessive collagen deposition at the site of the stricture.<br />

c. Other causes of intrinsic UPJ obstructions include,<br />

Valvular mucosal folds (kinks or valves).<br />

Persistent fetal convolutions.<br />

Upper ureteral polyps.<br />

High insertion of ureter.


Proforma<br />

The presence of these kinks, valves, bands or adhesions may also produce<br />

angulations of the ureter at the lower margin of the renal pelvis in such a manner that,<br />

as the pelvis dilates anteriorly and inferiorly, the ureteral insertion is carried further<br />

proximally. In these cases, the most dependent portion of the pelvis is inadequately<br />

drained. In at least some cases however, the high insertion itself is likely the primary<br />

obstructing lesion.<br />

Congenital folds are a common finding in the upper ureter of fetuses after the<br />

4 th month of development and may persist, until the newborn period. Such folds are<br />

mucosal infolds with as axial offshoot and adventitia that does not flatten out when<br />

the ureter is distended or stretched. These epithelial folds are secondary to<br />

differential growth rates of the ureter and the body of the child, with excessive<br />

ureteral length occurring early in gestation. This provides a “length reserve” for the<br />

ureter, which traverses a shorter distance in the new born than in the adult (Ostling,<br />

1942) 15 . Ostling thought these folds were a precursor of UPJ obstruction, because<br />

they were frequently discovered in babies who had a contralateral UPJ obstruction.<br />

This concept has evolved, and “Ostling’s folds” are now considered folds that are not<br />

obstructive and disappear with a person’s linear growth. They are rarely seen in an<br />

older child or adult. On the other hand, persistent fetal folds containing muscle and<br />

high insertion of a valvular leaflet at UPJ may become obstructive (Maizels and<br />

Stephens, 1980). This type of obstruction sometimes can be relieved by dissection of<br />

the folds and elimination of the kinking (Johnston, 1969), but more commonly the<br />

ureteral portion containing the valve must be excised.


2. Extrinsic causes:<br />

Proforma<br />

An aberrant, accessory, or early branching lower pole vessel is the most<br />

common cause of extrinsic UPJ obstruction. This is a major case of UPJ obstruction<br />

in adults.<br />

These vessels pass anteriorly to the UPJ or proximal ureter and contribute to<br />

mechanical obstruction. Nixon (1953) reported that 25 of 78 cases of UPJ<br />

obstruction were secondary to vascular compression. Other reported incidences have<br />

varied between 15% and 52% (Ericsson et al, 1961; Williams and Kenawi, 1976,<br />

Johnson et al, 1977; Stephens, 1982; Lowe and Marshall, 1984). Whether the<br />

aberrant vessel causes obstruction or is a co-variable that exists along with an<br />

intrinsic narrowing is unclear.<br />

Stephens (1982) theorized that when an aberrant or accessory renal artery to<br />

the lower pole of the kidney is present and the ureter courses behind it, the ureter may<br />

angulate at both the UPJ and the point at which it traverses over the vessel as the<br />

pelvis fills and bulges inferiorly. Further angulations of the ureter occurs as it<br />

becomes adherent to the UPJ secondary to an inflammatory process. A two-point<br />

obstruction ensues, with kinking of the ureter at the UPJ and at the point where the<br />

ureter drapes over the vessel. Stephens (1982) could find no evidence of stricture or<br />

fibrosis at these points when the ureter was freed of its adhesions and lifted off the<br />

vessel. However, he suggested that over time, these areas may become ischemic,<br />

fibrotic, and finally stenotic 16 .


II) Secondary or acquired causes of UPJ obstruction:<br />

Proforma<br />

UPJ obstruction may also be seen with severe vesico-ureteral reflux (VUR);<br />

these conditions co-exist in 10% of cases. The ureter elongates and develops<br />

a tortuous course in response to the obstructive element of reflux. A kink may<br />

develop in the UPJ area, a point of relative fixation, and may cause<br />

obstruction secondarily (Lebowitz and Blickman, 1983) 17 . In such a situation<br />

the obstructive lesion needs to be corrected initially, even though the VUR<br />

contributed to the initial problem.<br />

Urothelial tumours.<br />

Calculi at ureteropelvic junction.<br />

Associated anomalies:<br />

Congenital renal malformations are commonly seen in association with UPJ<br />

obstruction. (about 50% of affected infants).<br />

UPJ obstruction is the most common anomaly encountered in the opposite<br />

kidney (occurs in 10-40% of cases) 6 .<br />

Renal dysplasia and multicystic dysplastic kidney are next most commonly<br />

observed contralateral lesions 18 .<br />

Unilateral renal agenesis (5% of children) 19 .<br />

Duplicated collecting system or horseshoe kidney. UPJ obstruction may<br />

occur in either the upper or the lower moiety of duplicated collecting<br />

system 20 .<br />

UPJO was noted in 21% of children with VATER (vertebral defects,<br />

imperforate anus, tracheo-esophageal fistula, radial and renal dysplasia).


Clinical features:<br />

Proforma<br />

The presenting symptoms of UPJ obstructions have been documented to be<br />

varied and somewhat age dependent.<br />

Most infants are asymptomatic:<br />

- In children younger than 1 year old, the most common presentation has been a<br />

palpable abdominal mass 20,21 . Any palpable flank mass in an infant should raise<br />

the question of HN, since 50% of all palpable abdominal masses in infants and<br />

children are of renal origin 22 . Urinary tract infection was the presenting symptom<br />

as often as a flank mass in a large series of patients of UPJ obstruction performed<br />

by Johnston and colleagues 23 .<br />

In older children, urinary tract infection (UTI) with fever has been reported to<br />

be the most common presenting complaint (30%) 24 .<br />

Other clinical presentations include,<br />

Abdominal or flank pain.<br />

Chronic nausea and vomiting<br />

Hematuria following mild or unrecognized trauma (25%).<br />

This hematuria is believed to be caused by disruption and rupture of mucosal<br />

vessels in the dilated collecting system (Kelalis et al, 1971)<br />

Hypertension:<br />

The pathophysiology is thought to be a functional ischemia with reduced<br />

blood flow caused by the enlarged collecting system that produces a renin-<br />

mediated hypertension (Belman et al, 1968).<br />

Failure to thrive.


Diagnosis:<br />

Proforma<br />

The diagnosis of UPJ obstruction is based on the combination of clinical<br />

manifestations, radiographic evidence of obstruction and impairment of renal<br />

function.<br />

Radiographic evidence plays a key role in the diagnosis of UPJ obstruction.<br />

Radiographic studies should be performed with a goal of determining both the<br />

anatomic site and the functional significance of an apparent obstruction<br />

1. Excretory urography or intra venous pyelography (IVP):<br />

Remains a cornerstone of radiographic diagnosis 24 .<br />

Classically, findings on the affected side include:<br />

Delay in function associated with a dilated pelvicalyceal system.<br />

If ureter is visualized, it should be of normal caliber. In some patients,<br />

symptoms may be intermittent and IVP in between painful episodes may<br />

be normal. In such cases, the study should be repeated during an acute<br />

episode when the patient is symptomatic. Alternatively, provocative<br />

testing with a diuretic urogram may allow accurate diagnosis. The patient<br />

should be well hydrated and the study then performed by injecting<br />

furosemide, 0.3-0.5 mg/kg, intravenously at the time of IVP.


PHOTOGRAPH. 1 : IVP<br />

Proforma<br />

IVP showing bilateral dilated pelvicalyceal system due to bilateral PUJO


2. Renal ultrasound (USG) 3 :<br />

Proforma<br />

It is a valuable initial diagnostic study under any circumstances in which<br />

overall renal function is inadequate to perform IVP. USG is the standard method for<br />

identifying HN in infancy. The size of the renal pelvis (Antero-posterior diameter)<br />

can correlate with the likelihood of obstruction, but this does not diagnose<br />

obstruction, nor can it answer whether the HN will improve or worsen.<br />

Postnatal USG imaging is usually deferred until day 3 of life, to allow for<br />

improvement in the relative oliguria, which could lead to underestimation of the<br />

degree of HN.<br />

The fetal and neonatal kidney may appear to be hydronephrotic on USG<br />

secondary to the sonolucent appearance of the medullary area and pyramids. This<br />

appearance tends to resolve after parenchymal maturation, which occurs at 3 months<br />

of age. Sequential studies become meaningful, because they define a trend with<br />

regard to the HN. Worsening HN usually indicates obstruction, and improved HN<br />

suggests the opposite.<br />

In neonates and infants, the diagnosis of UPJO has generally been suggested<br />

either by routine performance of maternal USG or by the finding of a flank mass. In<br />

either setting, renal USG is usually the first radiographic study performed.<br />

USG should be able to visualize dilatation of the collecting system. In UPJO,<br />

the pelvis is visualized as a large, medial sonolucent area surrounded by smaller,<br />

rounded sonolucent structures representing dilated calyces. At times, dilated calyces<br />

will be seen connecting to the pelvis via dilated infundibula. Occasionally, a solid-<br />

appearing renal cortex can be seen surrounding the sonolucent areas or separating the<br />

dilated calyces.


Proforma<br />

Currently computed tomography (CT) scanning is being performed in most<br />

patients in place of USG, (Fielding et al, 1997, Dalrymple et al, 1998; Vieweg et al,<br />

1998). Both USG and CT scanning have a role in differentiating acquired causes of<br />

obstruction such as radiolucent calculi or urothelial tumours.<br />

PHOTOGRAPH. 2 : RENAL USG<br />

Renal USG showing Rt. Kidney Hydronephrosis due to PUJO<br />

PHOTOGRAPH. 3 : CT SCAN OF KUB<br />

CT scan showing right kidney HN due to PUJO


3. Magnetic resonance imaging (MRI) 3 :<br />

Proforma<br />

This offers advantages for evaluating renal blood flow, anatomy and urinary<br />

excretion. After injection of contrast gadolinium – diethylenetriamine – penta-acetic<br />

acid (DTPA), signal intensity from the region of interest of hydronephrotic kidneys<br />

differed from that of non-hydronephrotic kidneys by showing less cortical decrease,<br />

and delayed contrast excretion. These techniques are beginning to gain acceptance<br />

and hold the promise for a single study that can provide information on both<br />

perfusion and function. The evaluation of renal perfusion with MRI has become<br />

feasible with the development of rapid data acquisition techniques, which provide<br />

adequate temporal resolution to monitor the rapid signal changes during the first<br />

passage of contrast agents in the kidneys (Bennett and Li, 1997).<br />

PHOTOGRAPH. 4 : M.R. UROGRAM<br />

M.R. Urogram showing dilated pelvis in the Lt. Kidney due to PUJO.


4. Radionuclide renography 3 : (Renal scientigraphy)<br />

Proforma<br />

IVP was in the past the primary radiographic study used to define UPJO. In<br />

most institutions, this has been supplanted by radionuclide renography, which<br />

provides differential renal function data and an assessment of washout from the<br />

individual kidney. Several radiopharmaceuticals have been used, each with slightly<br />

different properties.<br />

Diethylenetriamine-penta-aceticacid (DTPA) is eliminated entirely by<br />

glomerular filtration, with an extraction efficiency of 20%. It provides indirect means<br />

of measuring the GFR.<br />

Differential GFR can be measured by comparing the amount of uptake in each<br />

kidney during the first 1 to 3 minutes after intra venous injection (Rowell et al, 1986).<br />

Mercaptoacetyltriglycine (MAG-3) is cleared by the kidneys primarily by<br />

tubular excretion and to a lesser extent by glomerular filtration. Therefore MAG-3 is<br />

an excellent agent for estimating renal plasma flow. Differential renal plasma flow<br />

measured with MAG-3 correlates reasonably well with differential renal function.


Proforma<br />

PHOTOGRAPH 5 : RENAL SCIENTIGRAPHY WITH Tc-99m DTPA SCAN<br />

A : Renal scientigraphy showing decreased function in the left kidney<br />

B : Renal scientigraphy showing delayed excretion of dye in the left kidney


Tc-99m DTPA scan:<br />

Procedure 25 :<br />

Bladder catheterization should be done with Foley catheter.<br />

Proforma<br />

Patient is usually hydrated well intravenously with 10-15ml/kg of 5% dextrose +<br />

0.22% normal saline for under 1 year of age and 5% dextrose + 0.45% normal<br />

saline for over 1 year of age for 30min prior to administering the diuretic.<br />

Administration of radiopharmaceuticals:<br />

Tc-99m DTPA is a glomerular agent. The biological half-life is under 2.5 hrs,<br />

95% of the administered dose is cleared by 24 hours.<br />

The minimal administered activity for Tc-99m DTPA is about 0.5mCi. The<br />

maximum administered activity for Tc-99 DTPA is about 10-20mCi in<br />

teenagers who weigh over 70 kgs.<br />

Administration of diuretic:<br />

The dose of furosemide (Lasix) is 1.0mg/kg with maximum dose of 40mg.<br />

The diuretic is injected at 20min or later after the radiopharmaceutical (F+20<br />

or later) when the renal pelvis and ureter become maximally distended in HN.<br />

Image acquisition:<br />

The preliminary study is a dynamic renal scan with the patient in supine with<br />

his/her back to the camera and acquisition for 20 to 30min as serial 15 to 30<br />

sec images. After first few min, 30 to 60 sec images may be acquired.<br />

For diuretic of F+20 or later, continuous computer and analog acquisitions are<br />

begun one to two min prior to the administration of the diuretic (baseline<br />

phase) and for the rest of the study the diuretic effect usually begins within 1<br />

to 2 min after the administration of the diuretic.


Processing:<br />

Proforma<br />

From the dynamic renal study, careful evaluation of the parenchymal phase<br />

reveals renal function, size and position. Cortical transit time and dilatation of<br />

the collecting system are examined on the excretory phase.<br />

Baseline images of the diuretic phase are used for the assessment of the<br />

diuretic effect.<br />

Regions of interest are drawn around the dilated pelvicalyceal system for<br />

curve analysis and calculation of the T ½. The diuretic half time is the time at<br />

which the time activity curve decreases to half of its maximal activity.<br />

Residual activity can be reported by estimating the percentage of the initial<br />

tracer activity that remains at 30min after the injection of the<br />

radiopharmaceutical.<br />

Interpretation criteria :<br />

In absence of obstruction there is rapid and almost complete washout of the<br />

radiotracer. Obstructed systems can result in delayed drainage from the<br />

collecting system. The amount of activity proximal to the obstruction can also<br />

increase with time.<br />

With the injection of the diuretic after the radiopharmaceutical (F + 20 or<br />

later), a T ½ less than 10min usually means the absence of obstruction, where<br />

a T ½ greater than 20min identifies obstruction. The T ½ with a value between<br />

10 and 20 is an equivocal result.<br />

The shape of the resulting time activity curves of the washout study has been<br />

used for differentiation of stasis from obstruction. Persistence of more than 50% of<br />

initial immediate pre-furosemide activity for more than 20 minutes is considered to<br />

be diagnostic of obstruction.


Proforma<br />

A nuclear scan is also of value in predicting recoverability of function in those<br />

cases in which IVP has revealed non-visualization. In this setting, a 99mTc-DTPA<br />

scan can help predict recoverability of function, because essentially all kidneys that<br />

function on such scans will improve following relief of obstruction. DTPA scan will<br />

also be of value in differentiating dilated, non obstructed systems from those with<br />

functional obstruction.<br />

Roake and Sandler (1998) reviewed in detail the role of diuretic renography<br />

for evaluation of UPJO.<br />

5. Invasive tests:<br />

Retrograde pyelography is indicated whenever the UPJO requires acute<br />

decompression such as in setting of infection or compromised renal function. In such<br />

cases, an attempt can be made to pass a floppy tipped guide wire or hydrophilic<br />

“glide” wire, followed by open-ended ureteral catheter or internal stent, to allow<br />

decompression of the system and thus better prepare the patient for reconstruction at<br />

a later date.<br />

In cases in which cystoscopic retrograde manipulation has been unsuccessful<br />

or may be hazardous, such as in male neonates or infants placement of percutaneous<br />

nephrostomy is an excellent alternative. This also allows the performance of<br />

antegrade studies that will help define the nature and exact anatomic site of<br />

obstruction.


Whitaker test 3 :<br />

Proforma<br />

First described by Whitaker in 1973 and then modified in 1978. The renal<br />

pelvis is perfused at 10cc/ min with NS solution. Alternatively, dilute radiographic<br />

contrast solution may be used and the procedure performed under fluoroscopic<br />

control.<br />

Renal pelvic pressure is monitored during the infusion and the pressure<br />

gradient across the presumed area of obstruction is then determined. During infusion,<br />

the bladder is continuously drained with an indwelling catheter to prevent<br />

transmission of intervesical pressure. Renal pelvic pressure ranging up to 12-15 cm<br />

of H2O during this infusion suggests a non-obstructed system.<br />

In contrast, pressure in excess of 15-22 cm of H2O is highly suggestive of a<br />

functional obstruction. Pressure between these extremes may be non-diagnostic. This<br />

test has disadvantage of being invasive and indications for it are now infrequent and<br />

used primarily when other examinations are inconclusive. No evaluation of a child<br />

with suspected UPJO is complete until voiding cystourethrogram (VCUG) has been<br />

done to exclude VUR.<br />

As such there remains an important role for the urologist as a diagnostician to<br />

correlate the clinical presentation and results of all diagnostic studies performed in<br />

order to appropriately recommend the timing and nature of subsequent intervention.


MANAGEMENT :<br />

Surgical management :<br />

Proforma<br />

The evolution in the surgical correction of UPJ obstruction has occurred on a<br />

number of fronts, with open surgical techniques yielding way to endoscopic and<br />

laparoscopic approaches. Although there are a variety of surgical approaches to<br />

correction of UPJ obstruction, they can be classified into 3 categories.<br />

1. Open surgical procedures.<br />

2. Endoscopic (antegrade or retrograde) procedures.<br />

3. Laparoscopic procedures.<br />

1. OPEN SURGICAL PROCEDURES:<br />

The open surgical techniques that have the greatest applicability can be<br />

classified into 3 main groups.<br />

a. The dismembered pyeloplasty<br />

b. Flap procedures<br />

c. The incisional - intubated type<br />

The Anderson-Hynes pyeloplasty (1949) has become the most commonly<br />

employed ‘open’ surgical procedure for the repair of UPJ. Open pyeloplasty for<br />

correction of UPJO remains the gold standard against which all alternative therapies<br />

are compared. The overall success rates of open pyeloplasty range from 90-100% 28,29 .<br />

The technique of dismembering the ureter was borne out of necessity in the<br />

repair of retrocaval ureter (Anderson and Hynes, 1949). There was reluctance on the<br />

part of surgeons elsewhere because of concerns about severing the neural continuity


Proforma<br />

between pelvis and ureter. Later work demonstrated that the bolus of urine is the<br />

peristaltic stimulus. The principal reasons for the universal acceptance of the<br />

dismembered pyeloplasty are:<br />

Broad applicability, including preservation of anomalous vessels.<br />

Excision of the pathologic UPJ and appropriate repositioning and<br />

Successful reduction pyeloplasty.<br />

Indications for intervention:<br />

Presence of symptoms associated with the obstruction.<br />

Impairment of overall renal function or progressive impairment of ipsilateral<br />

renal function.<br />

Development of stones or infection, rarely, causal hypertension.<br />

A. DISMEMBERED PYELOPLASTY 3 :<br />

This operation is easy to perform and can be accomplished by following<br />

surgical approaches.<br />

Anterior subcostal<br />

Flank incision<br />

Posterior lumbotomy<br />

The actual repair for the modified Anderson-Hynes dismembered pyeloplasty,<br />

as performed through an anterior subcostal incision, is explained in materials and<br />

methods section.


FIG No. 3 : DISMEMBERED PYELOPLASTY<br />

Proforma<br />

UPJ obstruction UPJ excised Anastomosis in a watertight fashion<br />

FIG No. 4 : DISMEMBERED PYELOPLASTY IN A LARGE OR REDUNDANT<br />

Large or<br />

redundant renal<br />

pelvis<br />

RENAL PELVIS<br />

Reduction<br />

pyeloplasty<br />

Dependent aspect of pelvis<br />

anastomosed to proximal<br />

ureter


Accessory lower<br />

pole vessel<br />

Anastomosis done<br />

anterior to the aberrant<br />

vessel<br />

Proforma<br />

FIG No. 5 : DISMEMBERED PYELOPLASTY IN ABERRANT OR<br />

ACCESSORY LOWER POLE VESSELS


OUTCOME :<br />

Proforma<br />

Adherence to sound surgical principles, minimal handling of the ureter at the<br />

time of repair and judicious use of internal stenting or nephrostomy tube drainage<br />

ensure a successful outcome. Success is defined as improvement in hydronephrosis<br />

and stabilization or improvement in function on renal scan along with a decrease in<br />

washout time. In those situations in which symptomatic presentation occurred,<br />

resolution of flank/abdominal pain or vomiting should also occur.<br />

Imaging of the kidneys postoperatively depends on whether a nephrostomy<br />

tube has been used. A nephrostogram performed 10 to 14 days after surgery allows<br />

for visualization of the anastomosis. Others have simply clamped the nephrostomy<br />

tube for 24 hours and checked the residual in the renal pelvis. If the residual is less<br />

than 15 ml, then the nephrostomy tube is removed (Flint et al, 1998). If a double-<br />

pigtail ureteral stent is left indwelling, it is removed 6 to 8 weeks after the initial<br />

procedure. A renal ultrasound is obtained 6 weeks after pyeloplasty or after stent<br />

removal to ensure that the hydronephrosis is improving. A renal scan is obtained 1<br />

year after the pyeloplasty to provide a relative assessment of the overall renal<br />

function. Long-term imaging at 3 years may be obtained to look for that rare situation<br />

of delayed cicatrisation and restenosis of the UPJ.


Selected published experience with open pyeloplasty :<br />

Source Patients/Kidneys Success (%)<br />

Poulsen et al., 1987 35 100<br />

O'Reilly, 19H9 30 83-93<br />

MacNeily el al, 1993 75 85<br />

Shaul el al, 1994 32/33 (2 month old) 93<br />

Salem et al, 1995 100 98<br />

McAlcer and Kaplan, 1999 79 90<br />

Austin el al, 2000 135/137 91<br />

Houben et al, 2000 187/203 93<br />

Proforma<br />

Early complications of pyeloplasty are uncommon and usually involve<br />

prolonged urinary leakage from the penrose drain. Depending on the amount of<br />

drainage, observation is generally the best approach. If it persists beyond 10 to 14<br />

days, placement of a retrograde ureteral stent can often rectify the situation.<br />

Spontaneously delayed opening of the anastomosis has occurred as late as several<br />

months after the repair. If a patient presents postoperatively with fever, flank pain,<br />

and significant hydronephrosis, a nephrostomy tube may be necessary to decompress<br />

the kidney. Lack of drainage for a prolonged period would necessitate further<br />

intervention, including an endopyelotomy, redo pyeloplasty, or even<br />

ureterocalicostomy. It is not advisable to embark on such a procedure before 2<br />

months postoperatively.


B. FLAP PROCEDURES 3 :<br />

Foley Y-V-plasty.<br />

Culp-Deweerd spiral flap.<br />

Scardino-Prince vertical flap.<br />

Foley Y-V-Plasty :<br />

Proforma<br />

The Foley Y-V-plasty was originally designed for reconstruction of a UPJ<br />

obstruction associated with a high ureteral insertion. As for other flap techniques,<br />

however, its use has generally been supplanted by the more versatile dismembered<br />

pyeloplasty.<br />

Contraindications :<br />

Contraindicated when transposition of lower pole vessels is required.<br />

2. The Foley Y-V-plasty is also of little value when significant reduction of renal<br />

pelvic size is required.<br />

Procedure :<br />

The pelvis and proximal ureter are exposed, and a widely based triangular or<br />

V-shaped flap is outlined with methylene blue or fine stay sutures. The base of the V<br />

is positioned on the dependent, medial aspect of the renal pelvis and the apex at the<br />

UPJ. The incision from the apex of the flap (the stem of the Y) will then be carried<br />

out along the lateral aspect of the proximal ureter. The incision in the ureter should<br />

be long enough to completely traverse the area of stenosis and extend for several<br />

millimeters into the normal caliber ureter.


Proforma<br />

The pelvic flap and ureterotomy are then developed. A fine scalpel blade is<br />

used for the initial pelvic incision, following which a Potts or a fine Metzenbaum<br />

scissors is used to complete the flap and ureterotomy. An internal stent is now placed<br />

and the repair performed over it. First, the apex of the pelvic flap is brought to the<br />

apex (inferior aspect) of the ureterotomy incision using fine absorbable suture. The<br />

posterior walls are then approximated using interrupted or running suture..<br />

Interrupted technique is less likely to cause local ischemia. Anastomosis of the<br />

anterior walls is then accomplished, thus completing the repair.<br />

High insertion of<br />

ureter<br />

V-flap V-Y plasty<br />

FIG No. 6 : FOLEY Y-V PLASTY


Culp-DeWeerd Spiral Flap :<br />

Proforma<br />

The Culp-DeWeerd spiral flap is best suited to large, readily accessible extra-<br />

renal pelves in which the ureteral insertion is already in a dependent, oblique<br />

position. Although most such patients are generally also good candidates for a<br />

standard or reduction dismembered pyeloplasty, the spiral flap may be of particular<br />

value when the UPJ obstruction is associated with a relatively long segment of<br />

proximal ureteral narrowing or stricture.<br />

Spiral<br />

flap<br />

outline<br />

Long<br />

proximal<br />

ureteral<br />

obstruction<br />

Spiral flap<br />

FIG No. 7 : CULP-DEWEERD SPIRAL FLAP<br />

Anastomosis<br />

The spiral flap is outlined with a broad base situated obliquely on the<br />

dependent aspect of the renal pelvis. To preserve blood supply to the flap, the base is<br />

situated in a position anatomically lateral to the UPJ, that is, between the ureteral<br />

insertion and the renal parenchyma. The flap itself may be spiraled posteriorly to<br />

anteriorly or vice versa. In either case, the anatomically medial line of incision<br />

(farthest from the parenchyma) is carried down the ureter, completely through the<br />

obstructed segment. Proper placement of the apex of the flap is determined by the<br />

length of flap needed. This is, in turn, a function of the length of proximal ureter to


Proforma<br />

be bridged. The longer the flap required, the farther away will be the apex from the<br />

base. However, to preserve vascular integrity of the flap, the ratio of flap length to<br />

width should not exceed 3:1. In general, the outline of the flap should be made longer<br />

than what may initially be perceived as necessary, because the flap will shrink once<br />

the pelvis is incised. If the flap is then in fact too long, excess length can safely be<br />

reduced by trimming back the apex, thus keeping blood supply intact. Once the flap<br />

is developed, the apex is rotated down to the most inferior aspect of the ureterotomy.<br />

The anastomosis is then performed over an internal stent, again utilizing fine<br />

absorbable sutures.<br />

Scardino-Prince Vertical Flap :<br />

The Scardino-Prince vertical flap technique has limited application today. It<br />

may appropriately be used only when a dependent UPJ is situated at the medial<br />

margin of a large, square ("box-shaped") extrarenal pelvis. Its use in most instances<br />

has been supplanted by a standard dismembered pyeloplasty, although the vertical<br />

flap may be preferable for relatively long areas of proximal ureteral narrowing.<br />

However, whereas the vertical flap can bridge stenotic areas of average length, the<br />

procedure cannot produce as long a flap, and thus bridge as long a stricture, as the<br />

spiral flap.<br />

FIG No. 8 : SCARDINO-PRINCE VERTICAL FLAP<br />

Large, box-shaped extra renal pelvis Vertical flap<br />

Anastomosis


Proforma<br />

The vertical flap technique itself is similar to the spiral flap procedure except<br />

that the base of the flap is situated more horizontally on the dependent aspect of the<br />

renal pelvis, between the UPJ and the renal parenchyma. The flap itself is formed by<br />

straight incisions converging from the base vertically to the apex on either the<br />

anterior or the posterior aspects of the renal pelvis. Again, the site of the apex, and<br />

thus the length of the flap, is determined by the length of proximal ureter to be<br />

bridged. The medial incision is carried down the proximal ureter, completely through<br />

the strictured area and into normal-caliber ureter, using fine scissors. The apex of the<br />

flap is then rotated down and sutured to the most inferior aspect of the ureterotomy.<br />

Closure of the flap is then completed with interrupted or running fine absorbable<br />

sutures.<br />

C. INTUBATED URETEROTOMY :<br />

The intubated ureterotomy, popularized by Davis in 1943, is rarely used<br />

today. Its primary role was for repair of lengthy or multiple ureteral strictures. If<br />

these strictures are found in association with UPJ obstruction, the intubated<br />

ureterotomy may be combined with any of the standard pyeloplasty techniques.<br />

However, at least in principle, the Davis intubated ureterotomy would be best<br />

combined with a spiral flap procedure. Compared with the vertical flap, the spiral<br />

flap can be made longer. This allows more of the strictured area to be bridged by a<br />

pelvic flap, and thus leaves a shorter area to rely on healing by "secondary intention."<br />

In fact, though, in this specific setting, any flap technique would be preferable to a<br />

dismembered repair, at least in regard to preservation of blood supply and subsequent<br />

healing.


Proforma<br />

A flap is outlined as described earlier, with the ureterotomy to be carried<br />

completely through the long, strictured area. The flap is then developed, taking care<br />

to use minimal dissection of the ureter in order to preserve its blood supply. In<br />

contrast to uncomplicated pyeloplasties, nephrostomy tube drainage is routinely<br />

applied in these cases in order to divert the urine and prevent subsequent urinoma<br />

formation. Nephrostomy drainage in these cases also allows access for antegrade<br />

radiographic studies during the postoperative period.<br />

As originally described, the ureteral intubation was accomplished with a<br />

stenting catheter that was placed across the strictured area to the distal ureter or<br />

bladder. Proximally, it was brought out through the renal cortex alongside of a<br />

nephrostomy tube. Currently, most urologists would use a self-retaining, soft, inert,<br />

internal ureteral stent instead. The apex of the flap is now brought over the stent as<br />

far down as possible on the ureterotomy, and the flap is closed with interrupted or<br />

running absorbable suture. The distal aspect of the ureterotomy is left open to heal<br />

secondarily by ureteral regeneration, although a few fine absorbable sutures may be<br />

placed loosely to keep the sides of the ureter in accurate relation to the stent.<br />

Spiral<br />

flap<br />

FIG No. 9 : INTUBATED URETEROTOMY<br />

Long<br />

ureteral<br />

strictures<br />

Spiral<br />

flap<br />

Distal<br />

ureterotomy<br />

left open over<br />

ureteric stent<br />

to heal<br />

secondarily


Proforma<br />

A nephrostogram should be obtained after 6 to 8 weeks. If there is no<br />

extravasation, the internal stent is removed cystoscopically and antegrade<br />

radiographic studies are then repeated. When ureteral patency has been ensured,<br />

without evidence of extravasation, the nephrostomy tube is clamped and<br />

subsequently removed.<br />

MANAGEMENT OF FAILED OPEN PYELOPLASTY:<br />

(“SALVAGE” PROCEDURES) 3 :<br />

Management of a failed open pyeloplasty is a challenging problem that is<br />

usually best managed initially using an endourologic approach. Occasionally,<br />

however, these techniques are not applicable or have already failed, as either the<br />

primary or the secondary procedure. In such cases, successful reconstruction can at<br />

times be achieved utilizing one of the flap or dismembered techniques already de-<br />

scribed. In this setting, the secondary open operative reconstruction will be aided by<br />

preliminary cystoscopic or ante-grade placement of a ureteral catheter to aid<br />

intraoperative identification and dissection of the ureter and renal pelvis. In these<br />

cases, there is often a relatively long length of proximal ureteral stenosis to repair. As<br />

such, in contrast to primary repairs in which dissection of the kidney and ureter is to<br />

be minimized, wide mobilization of both is generally a necessity. This allows the<br />

kidney to be displaced downward and the ureter up, thus helping to bridge the area of<br />

stenosis and perform the secondary pyeloplasty without tension.<br />

Several other options are available for these secondary and often complex<br />

repairs. Many of these surgical alternatives are those generally available for any<br />

extensive ureteral problem. Options for preserving renal function include an<br />

ileoureteral replacement and autotransplantation with a Boari flap pyelovesicostomy.<br />

For cases in which function of the involved kidney is already significantly compro-


Proforma<br />

mised and the contralateral kidney is normal, consideration can also be given to<br />

nephrectomy, especially when previous attempts at salvage have already failed or the<br />

repair would be particularly complex for any reason. Another option, more specific to<br />

the "failed pyeloplasty," is use of a ureterocalycostomy.<br />

Ureterocalycostomy :<br />

Anastomosis of the proximal ureter directly to the lower calyceal system has<br />

become a well-accepted salvage technique for the failed pyeloplasty (Ross et al,<br />

1990). Ureterocalycostomy may also be utilized as a primary reconstructive<br />

procedure whenever a UPJ obstruction or proximal ureteral stricture is associated<br />

with a relatively small intrarenal pelvis, or, in the view of some authors, when the<br />

UPJ is associated with rotational anomalies such as horseshoe kidney (Levitt et al,<br />

1981). In those cases, it may be of particular value because it provides completely<br />

dependent drainage.<br />

The ureter is isolated in the retroperitoneum and dissected proximally as far as<br />

possible with a large amount of periureteral tissue. For secondary procedures,<br />

extensive scarring may preclude identification and dissections of the renal pelvis<br />

itself. The kidney is then mobilized as much as necessary to gain access to the lower<br />

pole. An important technical point to be emphasized is that the parenchyma overlying<br />

the lower pole calyx must be resected rather than simply incised (Couvelaire et al,<br />

1964). The amount of parenchyma to be removed depends on the extent of cortical<br />

thinning already present. However, again, a simple nephrotomy over a calyx will not<br />

be adequate, because a secondary stricture may result.<br />

The proximal ureter is spatulated laterally and the ureterocalyceal anastomosis<br />

performed over an internal stent. Consideration should also be given to leaving a


Proforma<br />

nephrostomy tube in these cases. The first suture is placed at the apex of the ureteral<br />

spatulation and lateral wall of the calyx, and the second one is placed 180 degrees<br />

away. The remainder of the anastomosis is then completed utilizing an interrupted<br />

"open" suture technique. That is, each suture is placed but is left untied until the final<br />

one is in place. This allows a more accurate anastomosis to be performed under direct<br />

vision. When the full set of circumferential sutures has been placed, they are secured<br />

down together.<br />

Whenever possible, the renal capsule is closed over the cut surface of the<br />

parenchyma, but not close enough to the anastomosis itself to compromise its lumen<br />

by extrinsic compression. Rather, the anastomosis should be protected by<br />

surrounding it with perinephric fat or a peritoneal or omental flap. A follow-up<br />

urogram is generally obtained 1 month after stent extraction.<br />

2. ENDOSCOPIC PROCEDURES :<br />

Several less invasive alternatives to standard operative reconstruction are now<br />

available. The advantages of all these newer approaches include a significantly<br />

reduced length of hospital stay and post operative recovery. However, for many of<br />

these procedures, the success rate does not approach that of standard open<br />

pyeloplasty. Further more open operative intervention can be applied to almost any<br />

anatomic variation of UPJ obstruction. Consideration of any of the less invasive<br />

alternatives must take into account individual anatomy including, but not limited to<br />

the degree of HN, overall and ipsilateral renal function and, in some cases, the<br />

presence of crossing vessels or concomitant calculi.<br />

Endourologic management of UPJO was introduced by Ramsan and<br />

colleagues in 1984 as a “percutaneous pyelolysis” and then popularized in the US by


Proforma<br />

Badlani and Coworkers 30 . The basic concept involves a full thickness incision<br />

through the obstructing proximal ureter, from the ureteral lumen out to the peripelvic<br />

and periureteral fat. The incision is stented and left to heal, based on the original<br />

work of Davis in 1943, who used an intubated ureterotomy in the course of an open<br />

operative procedure for UPJO. The endoscopic approach to the UPJ has been<br />

successful in both an anterograde and retrograde fashion. The initial attempts at a<br />

balloon dilatation have been superceded by the use of an Acucise device (Applied<br />

Medical, Ureteral cutting balloon catheter, No. 5 Fr) 31 . Success rates ranging from<br />

75% to 88% have been reported in different series using endopyelotomy and<br />

endoureterotomy techniques 32,33,34 .<br />

Types :<br />

A. Percutaneous endopyelotomy<br />

Indications : (are similar to open pyeloplasty)<br />

Presence of symptoms<br />

Progressive or overall impairment of renal function<br />

Development of upper tract stones or infection or rarely, causal<br />

hypertention.<br />

Contraindications :<br />

Long segment (>2cms) of obstruction<br />

Active infection<br />

Untreated coagulopathy<br />

Impact of crossing vessels is controversial.<br />

Significant entanglement of the UPJ by crossing vessels renders any<br />

endourologic approach unsuccessful.


Technique :<br />

Proforma<br />

First, access across the UPJ is established. This can be accomplished is a<br />

retrograde fashion cystoscopically or in an antegrade manner percutaneously.<br />

With the patient in prone position, the site for percutaneous access is chosen<br />

to allow easy access to the UPJ utilizing rigid instrumentation. Generally mid<br />

posterior or superolateral calyx is chosen.<br />

The endopyelotomy is performed using a cold-knife technique under direct<br />

vision. With one, or preferably two wires in place across the UPJ, a direct vision<br />

“endopyelotome” is utilized. This hook-shaped cold knife is used to completely<br />

incise the UPJ in a full thickness manner, from the ureteral lumen out to periureteral<br />

and peripelvic fat. This incision is extended for several millimeters into the normal<br />

ureter. Once incision is complete, stenting is accomplished. A No 14/7 Fr<br />

endopyelotome may be utilized and this is passed in an antegrade fashion with the<br />

larger diameter end of the stent positioned across the UPJ. Nephrostomy is performed<br />

to ensure proper positioning of a patent stent. Percutaneous management is ideal<br />

when the UPJ obstruction is associated with upper tract stone disease, because the<br />

stones can be managed concomitantly.<br />

Results :<br />

Excellent success rates have been achieved by many surgeons and one should<br />

expect that 85% of patients would have good results.<br />

Gerber and Lyon 35 , in 1994, reviewed the outcome of percutaneous<br />

endopyelotomy in 672 patients reported from 12 centres and found a success rate<br />

ranging from 57% to 100% (mean 73.5%) at follow-up ranging from 2 to 96<br />

months. Currently, success rates approaching 85% to 90% are being reported at<br />

experienced centres.<br />

Open operative or laparoscopic intervention is generally offered to any patient<br />

who has failed an endourologic approach.


Complications :<br />

Proforma<br />

1. Hemorrhage: It is a risk of any percutaneous procedure including<br />

endopyelotomy. Treatment should be conservative to start and this includes<br />

bed rest, hydration and transfusion as necessary. When continued bleeding<br />

does not respond to conservative measures, selective angiographic<br />

embolization should be done.<br />

2. Infection<br />

3. Persistent obstruction<br />

B. “Cautery wire Balloon” endopyelotomy :<br />

The use of cautery wire balloon for management of UPJO was first reported in<br />

a clinical series by Chandhoke and associates in 1993. Only standard cystoscopic<br />

techniques and real-time fluoroscopy are needed for its use.<br />

Technique :<br />

Indications and contraindication are similar to any endopyelotomy procedure.<br />

The procedure starts with retrograde pyelogram under fluoroscopic control. A<br />

non-conducting guide wire is passed in a retrograde fashion across the UPJ and then<br />

cautery wire balloon catheter is passed with the cutting wire positioned in the<br />

direction ultimately planned for incision.<br />

At this point the 3cc low-profile balloon is partially inflated.<br />

Hot wire electrocautery incision is then performed.<br />

The low profile balloon is filled with another 1 to 2 cms of dilute contrast<br />

medium as 60 to 70 W of pure cutting current are applied to the cautery balloon


Proforma<br />

wire for 2 to 3 seconds. The balloon is kept inflated for a few minutes. During<br />

deflation, extravasation of contrast material may often be noted at the UPJ. The<br />

cautery wire balloon catheter is now withdrawn completely. Stenting of the ureter is<br />

done.<br />

Results :<br />

Chandhoke and associates (1993) 36 reported a 67% complete resolution of<br />

symptoms and 85% improvement in radiographic appearance. Preminger and<br />

colleagues (1997) 37 reported an initial “Patency” rate of 77% at a mean follow-up of<br />

7-8 months.<br />

In 1999, Lechevallier and his associates 38 in France achieved success rate of<br />

75% for a median of 2 years. Nadler and associates (1996) noted subjective<br />

improvement in 61% pts and 81% patients had a patent UPJ based on domestic<br />

xenography.<br />

Complications:<br />

1. Hemorrhage<br />

2. Ureteral avulsion<br />

3. Stent related problems<br />

4. Detachment of cutting wire.


C. Ureteroscopic Endopyelotomy :<br />

Proforma<br />

The main advantages of an ureterosopic approach, compared with<br />

fluoroscopically guided hot-wire balloon incision, is that it allows direct visualization<br />

of the UPJ and assurance of a properly sited, full-thickness endopyelotomy incision.<br />

If any vessels are encountered, these are easily visualized and avoided during the<br />

procedure.<br />

Indications and contraindications are similar to other endopyelotomy<br />

procedure except for upper tract stones that are best managed by percutaneous<br />

approach.<br />

Technique : Done under GA (Or occasionally SA)<br />

A retrograde pyelogram is performed under fluoroscopic control to locate the<br />

ureteral insertion into the renal pelvis and the length of the obstructed segment of<br />

ureter.<br />

A hydrophilic guide wire is passed cystoscopically into pelvicalyceal system.<br />

The semi-rigid ureteroscope is passed alongside the guide wire to the level of UPJ.<br />

When using a semi-rigid ureteroscope, a 365µm holmium laser fibre is inserted<br />

through the working channel as the ureteroscope is positioned at the proximal extent<br />

of the UPJ of the renal pelvis itself. At a setting of 1.2 J and frequency of 10 to 15<br />

Hz, the UPJ is incised, usually in a posterolateral direction, while the ureteroscope is<br />

withdrawn back, down across the UPJ. This procedure is repeated and the incision<br />

gradually deepened to extend into the peripelvic and periureteral space. Ureteric<br />

stenting is done.


Results :<br />

Proforma<br />

Biyani and colleagues (1997) 39 achieved a success rate of 87.5% in a small<br />

group of patients with a mean follow up of 12 months.<br />

Renner and co-workers in 1998 40 reported a larger series of patients<br />

undergoing ureteroscopic laser endopyelotomy with success rate of 85%<br />

endopyelotomy.<br />

Tawfiek and associates (1998) 41 reported 87.5% success rate with minimum<br />

follow up of 6 months.<br />

Gerber and Kim (2000) 42 and Savage and Streem reported success rates<br />

exceeding 80% with follow-up as long as 5 years.<br />

Complications :<br />

Most complications are minor and related to stent migration.<br />

3. LAPAROSCOPIC PYELOPLASTY :<br />

Laparoscopic approach, in the hands of experienced surgeons, can provide an<br />

excellent alternative to both less invasive and more invasive procedures. In contrast<br />

to an endopyelotomy, this approach does allow an anatomic repair like that achieved<br />

with an open pyeloplasty Compared with open surgical intervention, however, the<br />

hospital stay associated with a laparoscopic approach is generally shorter and the<br />

length of disability significantly reduced.<br />

Indications :<br />

The indications for a laparoscopic repair are similar to those for either an<br />

endourologic or an open operative procedure. Essentially, the patient should have<br />

functionally significant obstruction, as defined by the presence of symptoms,<br />

ipsilateral upper tract infection, or progressively impaired or overall impairment of<br />

renal function.


Contraindications :<br />

Proforma<br />

Specific contraindications to this approach include only a long segment of<br />

obstruction, such that a normal-caliber proximal ureter cannot be brought to the renal<br />

pelvis without tension. Although the presence of renal calculi does not preclude<br />

performance of a laparoscopic pyeloplasty with simultaneous stone extraction, the<br />

presence of one or more pyelocalyceal stones that cannot be easily accessed at the<br />

time of the laparoscopic procedure suggests that an alternative approach may be more<br />

appropriate.) Additional specific advantages of a laparoscopic approach, compared<br />

with an endoscopic or an endourologic one, is the presence of aberrant crossing<br />

vessels that require transposition. In this respect, laparoscopic pyeloplasty is similar<br />

to open pyeloplasty. Likewise, a large, redundant renal pelvis can be reduced in size<br />

with a laparoscopic approach, again offering the same advantage as open operative<br />

intervention over endourologic management. Laparoscopic pyeloplasty was first<br />

reported in 1993 both by Schuessler and coworkers and by Kavoussi and Peters, who<br />

utilized a dismembered pyeloplasty technique.<br />

Procedure : Explained in detail in materials and methods section.


Table<br />

Proforma<br />

SELECTED PUBLISHED EXPERIENCE WITH LAPAROSCOPIC<br />

PYELOPLASTY


Proforma<br />

POSTNATAL MANAGEMENT OF ANTENATALLY DIAGNOSED<br />

URETEROPELVIC JUNCTION OBSTRUCTION (UPJO) :<br />

Hydronephrosis is the most common abnormality detected on prenatal<br />

ultrasound and accounts for approximately 50% of all prenatally deleted lesions. A<br />

meta-analysis by Thomas in 1990 revealed that the estimated incidence of detectable<br />

urinary tract dilatation in utero is 1 per 100 pregnancies but only 1 in 500 pregnancies<br />

are believed to be accomplished by significant urologic problems. Approximately<br />

50% of prenatally detected urinary tract dilatations are caused by UPJO 43,44 .<br />

The universal use of maternal USG 45 has led to the early detection of fetal<br />

hydronephrosis. The fetal kidney is detected by USG at 15 weeks of gestation. The<br />

internal renal architecture is better imaged at 20 weeks when the kidney is<br />

surrounded by fat. Fetal HN may be the result of several factors and does not<br />

necessarily indicate obstruction. VUR, congenital non-obstructive megaureter,<br />

transient HN, and Prune-belly syndrome are some examples of non-obstruction<br />

collecting system dilatation. The majorities of HN cases, detected antenatally are<br />

physiological and resolve spontaneously. In one large series of nearly 1000 woman,<br />

antenatal HN was detected in 1.4% and confirmed in 0.65% postnatally. HN<br />

secondary to obstruction is most commonly the result of UPJO. However, not all<br />

cases of UPJO require surgical repair. Homsy evaluated 60 renal units with<br />

pyelocaliectasis with renal sonogram, diuretic renography, and IVP. 21 renal units<br />

were partially obstructed or dilated without obstruction. Of the 17 renal units<br />

available for follow-up; 7 (41%) deteriorated, 8 (47%) improved, and 2 (12%)<br />

remained stable. Those renal units that deteriorated did so within 6 months. Homsy


Proforma<br />

recommended 6 months observation period and repeat diuretic renography in those<br />

patients in whom initial obstruction cannot be documented.<br />

With the universal use of maternal fetal USG 46 and common finding of fetal<br />

HN, Grignon and colleagues proposed a classification of inutero urinary tract<br />

dilatation. The classification grades dilatation on a scale ranging from 1 to 5. The<br />

AP diameter is measured.<br />

Classification of in utero urinary tract dilation :<br />

Grades Caliceal dilation Size of pelvis<br />

Grade I Physiologic 1 cm<br />

Grade II Normal calyces 1- 1.5 cm<br />

Grade III Slight dilation > 1.5 cm<br />

Grade IV Moderate dilation > 1.5 cm<br />

Grade V Severe dilation + atrophic cortex > 1.5 cm<br />

The sonographic diagnosis of prenatal UPJO requires significant<br />

pelvicaliectasis without an evidence of distended bladder, dilated ureter, ureterocele,<br />

or a dilated posterior urethra. The prenatal songographic diagnosis of UPJO is thus a<br />

diagnosis of exclusion. Current recommendations are that fetuses with an AP<br />

diameter of the renal pelvis of greater than 10 mm, an anteroposterior renal pelvis to<br />

anteroposterior renal cortex ratio of greater than 0.5 or with evidence of caliectasis<br />

after 24 weeks of gestation should be evaluated postnatally. Obstruction of UPJ<br />

usually occurs unilaterally, although the condition is bilateral in 21% to 36% of


Proforma<br />

patients diagnosed in infancy. The prognosis of unilateral UPJO is usually favorable<br />

because of the normal contra lateral kidney. Unilateral neonatal HN is associated<br />

with a 3.5% to 20% risk of ipsilateral renal deterioration in the postnatal period.<br />

Patients with bilateral UPJO are at a greater risk for poor outcome, because both<br />

kidneys may be compromised.<br />

POSTNATAL MANAGEMENT :<br />

Prenatally detected HN should be confirmed postnatally after 3 days of life<br />

because of neonatal dehydration and physiologic oliguria.<br />

Approximately, 20% of antenatally diagnosed upper urinary tract dilatations<br />

are not present on postnatal USG 47 . Currently, no single test can reliably predict<br />

whether a hydronephrotic kidney will deteriorate or improve. It seems reasonable to<br />

use USG to determine the functional significance of UPJO. The differential function<br />

of the hydronephrotic kidney as shown on a Tc-99m DTPA scan is used as a means<br />

of determining a threshold for intervention, with a differential function of less than<br />

35% considered to be an indicator for surgical intervention. If renal differential<br />

function is greater than 35% on the initial study, the patient can be followed<br />

conservatively with repeat USG at 3 months.


FIG No. 10 : PRENATAL DIAGNOSIS OF HN 48<br />

Postnatal USG at 3-5 days<br />

Proforma<br />

Normal Abnormal<br />

VCUG VCUG<br />

Normal VUR Normal<br />

USG at 3 mts Prophylactic antibiotics Diuretic renal scan<br />

< 40% Differential function >40% Differential function<br />

Delayed drainage<br />

Surgery Prophylactic antibiotic<br />

DRS and USG at 3-6<br />

months


MATERIALS AND METHODS<br />

Proforma<br />

The present study is a prospective randomized control trial comparing<br />

laparoscopic pyeloplasty and open pyeloplasty in the treatment of primary<br />

ureteropelvic junction (UPJ) obstruction conducted in the Department of Urology,<br />

K.L.E.S. hospital and MRC Belgaum during the period of 1 year from April 2004 to<br />

March 2005.<br />

Total of 30 patients were evaluated and operated for primary UPJ obstruction<br />

formed the clinical material for our study. The clearance form ethical committee was<br />

obtained before the start of study.<br />

Source of data :<br />

All cases of primary UPJ Obstruction of any age group who attended<br />

Department of Urology, K.L.E.S Hospital Belgaum, from April 2004 to March 2005<br />

formed our study group.<br />

Method of collection :<br />

Sample size – 30 patients.<br />

Sampling procedure: Total of 30 patients were selected and randomized into<br />

Follow-up :<br />

2 groups of 15 each using computer generated randomized table. 15 patients<br />

under went open pyeloplasty and 15 patients under went laparoscopic<br />

pyeloplasty.<br />

All patients were followed-up for a period of minimum 3 months to assess<br />

objective and subjective outcome. Routinely, in uncomplicated cases, ureteric stent<br />

removal was done at 6 weeks. Follow-up with 99m-Tc-DTPA scan was done at 3<br />

months to assess improvement in renal function. The total study period was for 15<br />

months.


SELECTION CRITERIA :<br />

a. Inclusion criteria :<br />

Proforma<br />

All cases of primary UPJO of any age group diagnosed clinically and / or<br />

radiologically (including both symptomatic and asymptomatic patients).<br />

b. Exclusion criteria :<br />

(i) Patients of secondary UPJO.<br />

(ii) Patients with long segments of UPJ obstruction in which normal caliber<br />

proximal ureter cannot be brought to the renal pelvis without tension.<br />

(iii) Patients with urinary tract infection and huge capacity pelvis.<br />

(iv) General contra-indications for Laparoscopic surgery (e.g. morbid obesity,<br />

major bleeding disorders, unacceptable anaesthesia risks, patients who do<br />

not tolerate the pneumoperitoneum).<br />

(v) Patients unfit for surgery due to comorbid medical conditions.<br />

(vi) Redo-surgeries or failed pyeloplasty.<br />

All patients were evaluated in detail. The diagnosis of primary UPJO was<br />

firmly established in all patients based on history, physical examination, renal<br />

sonography and scientigraphy. The risks of the operation were fully explained to the<br />

patients and their parents (in case of children), and included postoperative infection,<br />

bleeding, failed pyeloplasty, the need to convert to open surgery in case of<br />

laparoscopic pyeloplasty, damage to other viscera and adhesion formation.


The following investigations were done in all patients :<br />

1. Blood – complete hemogram, Bleeding time, Clotting time.<br />

2. Urine – Routine and Microscopy.<br />

Proforma<br />

3. Minirenals – Random blood sugar, Blood Urea, Serum Creatinine, Serum<br />

Electrolytes.<br />

4. Serology –HIV, HBSAg<br />

5. X-ray KUB<br />

6. Renal USG<br />

7. IVP<br />

8. 99 mTc- DTPA scan.<br />

9. CT scan / MR-Urogram of KUB (in selected patients).<br />

10. Chest X-ray and Electrocardiogram.<br />

Prior fitness was taken from a Physician/Paediatrician. Consent for surgery<br />

was taken from patients or patient’s parents. An enema was administered the night<br />

before surgery to ensure that the colon was empty.<br />

Anaesthesia :<br />

All patients were operated under general anaesthesia. A retrograde pyelogram<br />

was done in all patients before surgery to delineate UPJO and to rule out other<br />

associated anomalies such as VUR (vesico-ureteral reflux. An enema was<br />

administered the night before to ensure that the colon was empty. Intraoperative<br />

antibiotic was administered to minimize the risk of infection. The patient was<br />

catheterised before surgery and the catheter left on free drainage during the operation.


Position:<br />

Proforma<br />

The patient was positioned in a lateral position and secured by placing a sand<br />

bag to support the back. The patient was further stabilized by strapping the iliac crest<br />

to the operating table with an adhesive bandage. The patient was placed as close to<br />

the edge of the operating table as possible.<br />

Surgical technique:<br />

PHOTOGRAPH. 6 : POSITION OF THE PATIENT<br />

1. Anderson-Hynes dismembered open pyeloplasty.<br />

2. Laparoscopic Anderson –Hynes dismembered pyeloplasty.


1. ANDERSON-HYNES DISMEMBERED OPEN PYELOPLASTY :<br />

Procedure :<br />

Proforma<br />

The anterior subcostal incision is a muscle-splitting incision that is made.<br />

Each muscle layer encountered is split in the direction of the muscle fibers<br />

until Gerota's fascia is identified by sweeping the peritoneum medially. The<br />

fascia is then incised posteriorly over the lateral aspect of the kidney.<br />

The renal pelvis is identified by medial retraction on the peritoneum and<br />

lateral traction on the kidney. If the renal pelvis is significantly dilated, an<br />

angiocath can be inserted to decompress the pelvis and facilitate identification<br />

of the UPJ.<br />

Anterior exposure is usually better when a dismembered pyeloplasty is being<br />

performed. Once the ureter and UPJ are identified, a traction suture is placed<br />

anteriorly through the proximal ureter to minimize subsequent handling.<br />

The area of UPJ is dissected free to allow for a clear area to perform the<br />

anastomosis. Traction sutures may be placed in the renal pelvis superiorly,<br />

medially, laterally, and inferiorly to the UPJ. Once adequate ureteral length is<br />

confirmed and the pathology of UPJ identified, the ureter can be transected at<br />

the UPJ. If the ureter is short, the kidney is completely mobilized to determine<br />

whether it can be brought down sufficiently to allow for a primary tension-<br />

free anastomosis.<br />

After transection of the UPJ, the renal pelvis may not spontaneously drain<br />

until it is incised. This should be done after the site for anastomosis is chosen.<br />

The ureter is spatulated on the side opposite to the traction suture using Potts<br />

tenotomy scissors. The distance over which the ureter is opened is variable,<br />

until healthy ureter is encountered, which springs open when forceps are<br />

placed into it.


Proforma<br />

The portion of pelvis is excised, usually a diamond-shaped segment that is<br />

present within the traction sutures that were placed in the renal pelvis. It is<br />

better to leave too much renal pelvis than too little, especially when resecting<br />

along the medial aspect of the renal pelvis. Infundibula can be encountered if<br />

one is not careful.<br />

The ureter and renal pelvis are aligned to ensure that the anastomosis can be<br />

accomplished without tension. Ureteric stent ( double J stent ) of caliber 5-6<br />

Fr was placed in the ureter in all patients ( 3.5-4 Fr in case of children ). If a<br />

nephrostomy tube is to be used, it is placed at this time. An inferior calix is<br />

chosen, preferably where the overlying parenchyma is not too thick. A<br />

Malecot catheter works well and is positioned away from the repair to<br />

minimize the chance of the catheter causing urinary blockage through the<br />

reconstructed UPJ.<br />

The anastomosis is started by placing the first suture at -the apex of the "V" in<br />

the ureter and into the tip of the inferior pelvic flap. As the suture is tied<br />

down, the ureter and renal pelvis are brought together to minimize tension on<br />

the repair. A small feeding tube is placed into the ureter; it can be used to<br />

stabilize the ureter during the anastomosis. A "no-touch" technique is<br />

employed with the ureter to minimize trauma and edema to the ureteral tissue.<br />

Either interrupted sutures or a running closure may be used, depending on the<br />

surgeon's preference. The area of the initial anastomosis is critical to ensuring<br />

a watertight closure.<br />

Before the repair is completed, the renal pelvis is irrigated to remove any<br />

blood clots or debris that could obstruct the UPJ. If an indwelling JJ ureteral<br />

stent is employed, it should be placed now, with care taken to place the stent<br />

into the bladder and renal pelvis without kinking it.


Proforma<br />

A Penrose drain is placed adjacent to the repair and brought out through a<br />

separate stab wound.<br />

The kidney is returned to its native position, and perinephric fat, if available,<br />

is placed over the anastomosis.<br />

Closure of the three fascias is readily accomplished, followed by closure of<br />

Scarpa's fascia and subcuticular skin.<br />

A Foley catheter, which was placed at the beginning of the procedure, may be<br />

left in place for 24 to 48 hours postoperatively. The drain is removed<br />

postoperatively when output is less than 5cc/ 24 hrs.


OPEN PYELOPLASTY PROCEDURE<br />

Proforma<br />

PHOTOGRAPH. 7 : DISSECTION OF OBSTRUCTED UPJ IN LEFT<br />

KIDNEY<br />

PHOTOGRAPH. 8 : TRACTION ON PROXIMAL URETER BEFORE<br />

DISMEMBERING THE DILATED PELVIS


Proforma<br />

PHOTOGRAPH. 9 : DISMEMBERED ANDERSON-HYNES PYELOPLASTY<br />

BEING PERFORMED<br />

PHOTOGRAPH. 10 : ANASTOMOSIS OF PROXIMAL URETER TO THE<br />

REDUNDANT PELVIS IN A WATERTIGHT FASHION


Proforma<br />

PHOTOGRAPH. 11 : COMPLETED ANTERIOR ANASTOMOSIS<br />

PHOTOGRAPH. 12 : COMPLETED POSTERIOR ANASTOMOSIS


Proforma<br />

PHOTOGRAPH. 13 : INCISION WOUND AFTER THE PROCEDURE WITH<br />

DRAIN SEEN<br />

PHOTOGRAPH. 14 : EXCISED NARROWED PROXIMAL URETER


2. LAPAROSCOPIC ANDERSON – HYNES DISMEMBERED<br />

PYELOPLASTY 59 :<br />

Procedure :<br />

Proforma<br />

The first port was inserted by open laparoscopy using a blunt Hasson cannula<br />

through the umbilical skin crease. Purse string suture was secured tightly around the<br />

Hasson trocar. The abdomen was insufflated with CO2 to 10 - 12 mm Hg. One<br />

10mm and one 5mm (one 5mm and one 3mm in case of children) instrument ports<br />

were required; however correct placement of these ports was critical to the ease of<br />

performing the anastomosis. Occasionally an extra 5 mm port was placed for<br />

retraction purposes. The peritoneum overlying the exposed kidney was incised just<br />

lateral to and above the colonic flexure. The loose adventitia around the kidney was<br />

detached from the renal capsule. Once the correct plane was identified, the renal<br />

capsule was traced into the renal sinus until the renal pelvis was identified. The renal<br />

pelvis was further dissected free from medial side. The UPJ and the proximal ureter<br />

were identified. The adventitia around the proximal ureter and UPJ was cleared. The<br />

ureter was dismembered with a small cuff of renal pelvis, leaving a 1.5 - 2.0 cm<br />

pyelotomy to reanastomose to the ureter. The lateral wall of the ureter was opened<br />

longitudinally and spatulated for about 1.5 - 2.0 cm along its lateral margin. The UPJ<br />

and proximal ureter attached at this point to the spatulated ureter was then excised.<br />

The ureteropelvic anastomosis was performed with an 18 cm, 4/0 vicryl suture on a<br />

3/8 round body needle (or 6/0 vicryl in case of children). The first suture was placed<br />

at the apex of the spatulaled ureter from outside in and then driven through the most<br />

dependent part of the pyelotomy. The posterior anastomosis was completed running<br />

up the length of the spatulaled ureter and pelvis. A 0.025 inch guidewire was then


Proforma<br />

passed though the proximal ureter into the bladder. A 3 Fr multilength double -<br />

pigtail catheter (or 5 Fr double-pigtail catheter in adults) was passed over the<br />

guidewire into the bladder. The proximal end of the double pig-tail stent was then<br />

placed within the renal pelvis. The anterior anastomosis was then completed as a<br />

continuous layer. A Penrose drain is placed adjacent to the repair and brought out<br />

through one of the port wound. The port wounds are closed with a single stitch using<br />

vicryl 3/0 or 4/0.<br />

Standard equipment for laparoscopic pyeloplasty :<br />

10-mm laparoscope<br />

5-mm laparoscope<br />

Dilating trocars (one 12-mm trocar and two 5-mm trocars)<br />

Harmonic scalpel<br />

Macrobipolar forceps<br />

Two needle drivers<br />

Endoshears with disposable tip<br />

4-0 (dyed) Vicryl on SH-1 needle


PHOTOGRAPH 15 : LAPAROSCOPIC INSTRUMENTS<br />

Proforma


Proforma<br />

PHOTOGRAPH 16 : INSERTION OF TROCAR AND LAPAROSCOPES<br />

PHOTOGRAPH 17 : SHOWING ENLARGED PELVIS DUE TO PUJO


Proforma<br />

PHOTOGRAPH 18 : PELVIS BEING OPENED WITH GUIDEWIRE<br />

BEING SEEN<br />

PHOTOGRAPH 19 : RECONSTRUCTION OF UPJ<br />

PHOTOGRAPH : RECONSTRUCTION OF UPJ


Proforma<br />

PHOTOGRAPH 20 : RECONSTRUCTION OF UPJ BEING COMPLETED<br />

PHOTOGRAPH 21 : COMPLETED LAPAROSCOPIC PYELOPLASTY<br />

WITH A DRAIN THROUGH ONE OF THE PORT SITE


Postoperative care:<br />

Drain was removed when less than 5 cc / 24 hrs.<br />

Catheter was removed the next day.<br />

Proforma<br />

Oral fluids and feeding were started at the appearance of peristaltic bowel<br />

sounds.<br />

Post-operatively antibiotics and analgesics were continued for two days in all<br />

cases.<br />

Follow-up:<br />

In uncomplicated cases, ureteral stent was removed after 6 weeks.<br />

All patients were followed for urinary tract infection, and renal scientigraphy<br />

was repeated at 3 months.


Proforma<br />

PHOTOGRAPH 22 : PREOPERATIVE RENAL SCIENTIGRAPHY<br />

SHOWING REDUCED RENAL FUNCTION IN THE LEFT KIDNEY<br />

PHOTOGRAPH 23 : POSTOPERATIVE RENAL SCIENTIGRAPHY<br />

SHOWING IMPROVED RENAL FUNCTION IN THE LEFT KIDNEY


Proforma<br />

PHOTOGRAPH 24 : SHOWING POSTOPERATIVE SCAR AFTER 3<br />

MONTHS IN OPEN AND LAPAROSCOPIC PYELOPLASTY DONE IN A<br />

SAME PATIENT WHO HAD BILATERAL PUJO


ASSESSMENT OF SUBJECTIVE OUTCOME :<br />

Proforma<br />

The subjective outcome of there 2 groups was assessed based on response to<br />

the pain analog and activity questionnaire of Nadler et al 49 . This questionnaire<br />

assesses perceived pre-operative and postoperative pain on a scale of O (no pain) to<br />

100 (worst pain) and activity levels of O (bed rest) to 100 (full/unrestricted). In<br />

children who were less than 6 yrs of age, a pictorial pain analog scale was used and<br />

questionnaire was given to parents to mark.<br />

All patients received the same questionnaire. Patients were asked to comment<br />

on pain and activity level at the time of surgery and at the time of follow-up for<br />

ureteral stent removal, usually 6 weeks after the surgery. Pre-operative assessment of<br />

pain was based on memory and post operative assessment was based on current<br />

status.<br />

ASSESSMENT OF OBJECTIVE OUT COME :<br />

Objective out come of patients was assessed based on the results of the most<br />

recent renal USG, IVP and renal scientigraphy. These studies were compared to pre-<br />

operative USG, IVP and diuretic renal scans. Success was considered as<br />

improvement in radiographic appearance (less hydronephrosis, visible UPJ, and/or<br />

normalization of drainage or improvement in renal function on diuretic renal scan).<br />

The success rate, post operative complications, mean operative time, mean hospital<br />

stay/recovery time, mean time when oral feeding started and the cosmesis between<br />

both the (laparoscopic versus open) procedures were compared.<br />

Statistical analysis comparing the subjective and objective outcomes between<br />

these two procedures was done using Student’s unpaired and paired ‘t’ tests. P value<br />

was considered significant at < 0.005, very significant between 0.005-0.0001, and<br />

highly significant at


Proforma<br />

The analog pain and activity questionnaire assessing pre-operative and<br />

post- operative pain and activity level 49 :<br />

1. Please mark on the following scale the level of discomfort you experienced before<br />

your procedure.<br />

0____________________________________________ 100<br />

(No pain) (Worst pain)<br />

2. Please mark on the following scale the level of discomfort you experienced now,<br />

(6 weeks after the procedure)<br />

0 ____________________________________________100<br />

(No pain) (Worst pain)<br />

3. If before your procedure, your discomfort level was 100% what is your current<br />

level of discomfort?<br />

________________________________________________ (0-100%)<br />

4. Please mark on the following scale your level of activity before your procedure.<br />

0______________________________________________100<br />

(Bed rest) (Full activity)<br />

5. Please mark on the following scale your level of activity after the procedure<br />

(6 weeks).<br />

0______________________________________________100<br />

(Bed rest) (Full activity)


FIGURE No. 11 : PICTORAL ANALOG PAIN SCALE<br />

PAIN ASSESSMENT IN CHILDREN ( in less than 6 years of age )<br />

Proforma


OBSERVATIONS & RESULTS<br />

Proforma<br />

Total of 30 patients with primary UPJO who attended Department of Urology<br />

KLES and MRC Belgaum during a period of 1 year from April 2004 to March 2005<br />

were selected for the study. All the 30 patients were randomized into 2 groups of 15<br />

each. 15 patients under went open pyeloplasty and formed open pyeloplasty group,<br />

and remaining 15 patients who underwent laparoscopic pyeloplasty formed the<br />

laparoscopic pyeloplasty group. All cases were followed for a minimum of 3<br />

months.<br />

Sex Incidence :<br />

Out of 15 patients in open pyeloplasty group, 11 patients were males and 4<br />

patients were females and out of 15 patients in laparoscopic group, 11 were males<br />

and 4 patients were females.<br />

Table No. 1 : Sex Incidence<br />

Sex<br />

Open pyeloplasty<br />

(n=15) group<br />

Percentage<br />

(%)<br />

Lap pyeloplasty<br />

(n=15) group<br />

Percentage<br />

(%)<br />

M 11 73.3% 11 73.3%<br />

F 04 26.6% 04 26.6%


Laterality :<br />

Proforma<br />

Out of 15 patients in open pyeloplasty group, 4 patients had primary UPJO in<br />

the right kidney and 9 patients had UPJO in the left kidney and 2 patients had<br />

bilateral UPJO. Out of 15 patients in laparoscopic pyeloplasty group, 6 patients had<br />

primary UPJO in right kidney and 07 patients had UPJO in the left kidney and 2<br />

patients had bilateral UPJO.<br />

Table No. 2 : Laterality<br />

Laterality<br />

Age :<br />

Open<br />

pyeloplasty<br />

group(n=15)<br />

Percentage<br />

(%)<br />

Lap.<br />

pyeloplasty<br />

group(n=15)<br />

Percentage<br />

(%)<br />

Right 04 33.33% 06 40%<br />

Left 09 55.33% 07 46.6%<br />

Bilateral 02 13.33% 02 13.33%<br />

The average age of patients undergoing open pyeloplasty was 22.83 yrs<br />

(range-5mts-48yrs) and for those who underwent laparoscopic pyeloplasty was 20.42<br />

yrs (range-8 mts to 65 yrs).<br />

Table No. 3 : Age<br />

Open pyeloplasty group<br />

(n=15)<br />

Lap pyeloplasty group<br />

(n=15)<br />

Average age (in yrs) 22.83 yrs 20.42 yrs<br />

Range 5 mts-48 yrs 8 mts- 65 yrs


Graph 2 & 3<br />

Proforma


Symptoms :<br />

Proforma<br />

Most patients presented with pain in the loin region or asymptomatic mass per<br />

abdomen or both.<br />

Table No. 4 : Symptoms :<br />

Presentation<br />

Open<br />

pyeloplasty<br />

group (n=15)<br />

Percentage<br />

(%)<br />

Lap<br />

pyeloplasty<br />

group (n=15)<br />

Percentage<br />

(%)<br />

Pain 12 80% 09 60<br />

Mass per<br />

abdomen<br />

02 13.3 05 33.33<br />

Both 01 6.6 01 6.66<br />

Associated anomalies:<br />

Out of 15 patients in open pyeloplasty group, one patient had right solitary<br />

kidney (absent left kidney) and one patient had double moiety ureter on left side with<br />

lower moiety UPJO. Out of 15 patients in laparoscopic pyeloplasty group, one patient<br />

had a Horseshoe kidney with a contracted kidney on the contra lateral side and<br />

hypertension.<br />

Table No. 5 : Associated anomalies<br />

Associated anomaly Open pyeloplasty Lap pyeloplasty<br />

Right solitary kidney 01 -<br />

Horseshoe kidney - 01<br />

Double moiety ureter on left side<br />

with lower moiety UPJO.<br />

01 -


Graph 4 only<br />

Proforma


Table No. 6 : Postoperative complications<br />

Complication<br />

Open pyeloplasty<br />

group n=15<br />

Proforma<br />

Lap pyeloplasty<br />

group n=15<br />

Wound infection 2 0<br />

Post op ileus 0 2<br />

Post op fever 1 1<br />

Prolonged urine leak (>3 days) 0 2<br />

Anastomotic stricture 0 0<br />

DVT 0 0<br />

Recurrent UTI 1 1<br />

Stent dislodgement 0 0


Graph 6 only<br />

Proforma


Table No. 7 : Renal function on renal scientigraphy (GFR/min) in open<br />

pyeloplasty group (n=15)<br />

Preoperative<br />

(GFR/min)<br />

Postoperative<br />

(GFR/min)<br />

35 55<br />

30 60<br />

25 50<br />

30 55<br />

20 45<br />

27 53<br />

23 50<br />

34 58<br />

26 52<br />

32 60<br />

21 46<br />

33 56<br />

22 49<br />

32 53<br />

29 56<br />

Proforma


Graph 7<br />

Proforma


Proforma<br />

Table No. 8 : Renal function on renal scientigraphy (GFR/min) in laparoscopic<br />

pyeloplasty group (n=15)<br />

Preoperative<br />

(GFR/min)<br />

Postoperative<br />

(GFR/min)<br />

25 60<br />

29 55<br />

33 45<br />

28 47<br />

33 60<br />

25 49<br />

35 55<br />

30 57<br />

27 48<br />

23 49<br />

33 52<br />

34 59<br />

26 60<br />

23 46<br />

35 50


Graph 8<br />

Proforma


Proforma<br />

Table No. 9 Preoperative and postoperative pyeloplasty analog pain and activity<br />

scores :<br />

TABLE LANDSCAPE


Table No. 10 : Assessment of objective outcome :<br />

Parameter<br />

Operative time<br />

(in min)<br />

Time when<br />

oral feeds<br />

started<br />

(in days)<br />

Time when<br />

drain removed<br />

(in days)<br />

Hospital stay<br />

(in days)<br />

Open pyeloplasty<br />

group n=15<br />

Laparoscopic<br />

pyeloplasty group<br />

n=15<br />

Proforma<br />

Student’s<br />

unpaired `t’ test<br />

Mean ± S.D Mean ± S.D P value<br />

159.0000 21.3976 214.6667 32.2638 5.874x10 -6 (HS)<br />

1.4667 0.5164 2.3333 0.4880 5.89x10 -5 (HS)<br />

2.3333 0.4880 3.4000 0.6325 1.73x10 -5 (HS)<br />

9.0667 2.9633 6.4000 2.8486 0.018019 (S)


DISCUSSION<br />

Proforma<br />

Gold standard for repair of UPJ obstruction is open pyeloplasty and best<br />

clinical results are reported with complete dismembering techniques like the<br />

Anderson-Hynes procedure. The success rates of this technique are reported to be 90-<br />

100% 28,29 .<br />

Open surgical techniques result in significant peri and post-operative<br />

morbidity, post-operative pain and scar formation. In the hope of decreasing the<br />

surgical morbidity associated with the open approach, several minimally invasive<br />

procedures have evolved during past two decades, specifically antegrade and<br />

retrograde endopyelotomy 50,51,52 . The cumulative experiences with these procedures<br />

have shown fairly good success rate (61-89%) and a significant risk of bleeding.<br />

These minimal invasive endoscopic procedures were reported to have a good initial<br />

success rate; however long-term results even in highly selected cases are poor.<br />

Endopyelotomy became popular in the 1980’s and 1990’s as a minimally<br />

invasive technique with low complication rates, relatively short operating times and<br />

short convalescence period. The greatest drawback associated with these treatments<br />

is the risk of vascular injury. Sampaio has shown that, 72.2% of cases, crossing<br />

vessels can be found either anterior or posterior to the UPJ. These vessels can be<br />

injured during UPJ incision without prompt intra operative recognition, leading to<br />

significant bleeding. Faerber et al. reported two bleeding complications in their<br />

Acucise series of 32 patients (6.2%). Merety K et al. reported bleeding that required<br />

transfusion in 95 and 16% in their series of antegrade and retrograde<br />

endopyelotomies, respectively. Shalhav et al. compared the out comes obtained with<br />

the antegrade and the retrograde approach for treatment of UPJO. The objective<br />

success rate was 89% and 71% and 77% and 83% for primary and secondary non-<br />

calculus UPJO with the antegrade and retrograde approach, respectively.


Proforma<br />

More recently, laparoscopic procedures to treat UPJO have combined the<br />

advantages of minimally invasive procedures and safety and high success rates<br />

obtained with open surgical procedures. Since the end of the last decade,<br />

laparoscopic pyeloplasty has become increasingly popular. Success rates are quoted<br />

to be between 87-100% 53,54,55 . The procedure allows the identification of crossing<br />

vessels, excision of the diseased UPJ plus or minus a reduction pyeloplasty and a<br />

watertight anastomosis. In addition, the analgesic requirement, hospital stay and<br />

recovery period are considerably reduced compared to the open pyeloplasty.<br />

Schuessler et al. first introduced laparoscopic pyeloplasty in 1993 and a variety of<br />

authors have reported on their clinical experiences with this promising new<br />

technique. The techniques described, differed mainly in the way to perform<br />

pyeloplasty utilizing either a complete dismembering or a non-dismembering<br />

technique. Laparoscopic pyeloplasty can be performed via retroperitoneal or<br />

transperitoneal approach. Equivalent success rates have been quoted in the literature.<br />

In our study, we used transperitoneal approach for all patients in laparoscopic<br />

pyeloplasty group, as this approach offers ease in identifying, dissecting and<br />

mobilizing intra-abdominal structures, while the potential disadvantages include<br />

prolonged ileus, adhesion formation, and injury to adjacent viscera. The major<br />

advantage of retroperitoneoscopic approach is that it provides a direct route to the<br />

UPJ and thus allows access without interference from intra-abdominal structures.<br />

However, working space is limited, and the absence of anatomic landmarks makes<br />

dissection more cumbersome.


Proforma<br />

Soulie et al 56 , reported the results of a multi-institutional study in which 55<br />

retroperitoneal laparoscopic pyeloplasties were performed. The conversion rate was<br />

5.4%, the mean operative time was 185 minutes, and the complication rate was<br />

12.7%. Two patients required a secondary procedure because of anastomotic<br />

strictures, with an overall objective success rate of 88.9%.<br />

Bauer et al 57 . showed in his transperitoneal approach for laparoscopic<br />

pyeloplasty, an objective and subjective success rate of 98% and 90% respectively,<br />

with one surgical failure. Similarly, Moore et al. demonstrated a low incidence of<br />

complication, associated with no surgical failures, no open conversions, and a 97%<br />

objective success rates in their series. Recently, Jarrett et al. reported the results of<br />

their first 100 laparoscopic pyeloplasty cases. Of the 100 patients, 83 had primary<br />

UPJO and 20 underwent concomitant pyelolithotomy. The average operative time,<br />

blood loss, and hospital stay was 4.2 hours, 181ml, and 3.3 days respectively.<br />

Crossing vessels were found in 57% of the cases complications occurred in 13<br />

patients, and blood transfusion was necessary in 2 surgical failure was observed in 4<br />

patients, all of which occurred in first post operative year. The overall success rate<br />

was 96%. Importantly, the long follow-up period in this series (upto 6 years)<br />

confirmed the durability of results.<br />

In our present study, total of 15 patients who underwent open pyeloplasty,<br />

were in the age group of 5 months to 54 yr (mean age = 22.82yrs), male to female<br />

ratio was 2.75:1, Laterality, that is, involvement of right to left kidney was in the<br />

ratio of 1:2.25 and 2 cases had bilateral involvement (13.33%), both had undergone<br />

open pyeloplasty earlier in our institute. The associated anomaly was found in 2 of<br />

the 15 patients (13.33%). One of those had double moiety ureter on left side with<br />

lower moiety ureter UPJO and other patient had right solitary kidney. Other 15


Proforma<br />

patients who underwent laparoscopic pyeloplasty by transperitoneal approach, were<br />

in the age group of 9mts – 65 yrs (mean age = 20.42yrs), male to female ratio was<br />

2.75:1, Laterality that is involvement of right to left kidney was in the ratio of 1:2.25<br />

and 2 cases had bilateral involvement (13.33%), both had undergone open<br />

pyeloplasty, one at our institute and other outside. The associated anomaly was found<br />

in one patient in laparoscopic pyeloplasty group (6.66%) who had a horseshoe<br />

kidney.<br />

In the literature, it is mentioned that, UPJO occurs more commonly in males<br />

than females and the ratio that exceeds 2:13 and left sided lesions predominate<br />

(approximately 67%) and bilateral UPJO is present in 10-40% of cases. Our patient<br />

demographics are in concordance with the literature.<br />

The assessment of pain and activity level were assessed both pre- operatively<br />

and post-operatively using pain analog scale and activity questionnaire of Nadler et<br />

al. In both the groups the pain and activity level pre-operatively was assessed just one<br />

day prior to the surgery and post operatively pain and activity level were assessed<br />

after 6wks at the time of ureteral stent removal. Statistical analysis was done using<br />

student's unpaired and paired ‘t’ test.<br />

The mean pre-operative pain level in the open pyeloplasty group was<br />

61.3333%±S.D18.0739 and mean post-operative pain level at 6weeks was<br />

18%±S.D12.6491. The mean pre-operative activity level was 54.66%±S.D9.9043 and<br />

mean post-operative activity level at 6 weeks was 90.66%±S.D7.9881. The mean pre-<br />

operative pain level in laparoscopic group was 59.0%±S.D14.4173 and mean post-<br />

operative pain level at 6 weeks was 5.33%±S.D7.43223. The mean pre-operative<br />

activity level was 48.66%±3.5187 and mean post-operative activity level at 6weeks<br />

was 96.33%±4.8058. From the results we can assess that the difference between<br />

mean pre-operative pain level between open and laparoscopic pyeloplasty group was


Proforma<br />

not significant (P=0.69885, Student’s unpaired ‘t’ test) and the difference between<br />

mean pre-operative activity level between both the groups was not significant<br />

(P=0.1524, Student’s unpaired ‘t’ test). But, pain level between pre and post-<br />

operative levels in open and laparoscopic pyeloplasty group was significant<br />

(P=1.375x10 -8 for open pyeloplasty, P=1.55847x10 -13 for laparoscopic pyeloplasty<br />

group Student’s paired ‘t’ test) and the difference between activity level in both the<br />

groups was significant (P=6.156x10 -12 for open pyeloplasty, P=1.6167x10 -23 for<br />

laparoscopic pyeloplasty group, Student’s paired ‘t’ test). These results conclude that,<br />

laparoscopic pyeloplasty group patients had significant improvement in pain and<br />

activity level post operatively than those patients who had undergone open<br />

pyeloplasty.<br />

The renal scientigraphy with 99m-TC-DTPA was done pre-operatively to<br />

assess the split renal function and to know the severity of UPJ obstruction in all<br />

patients. Post-operatively, the renal scan with 99m-TC-DTPA was repeated at 3<br />

months of follow-up period in all patients. All patients in both the group showed<br />

improvement in glomerular filtration rate and demonstrated good drainage.<br />

The mean pre-operative GFR/min on 99m-TC DTPA renal scan in open<br />

pyeloplasty group was 34.600±S.D27.3673 and post-operative mean GFR/min at 3<br />

months was 53.20±S.D4.6012. The mean pre-operative GFR/min in laparoscopic<br />

pyeloplasty group was 29.2667±S.D4.337 and post-operative mean GFR/min at 3<br />

months was 52.800±S.D5.4929. There was no statistical significant difference<br />

between pre-operative (P=0.4621965, Student’s unpaired ‘t’ test) and post-operative<br />

(P=0.8303954, Student’s unpaired ‘t’ test) improvement in GFR on renal scan<br />

between both the groups. All patients from both the groups showed improvement in<br />

GFR and demonstrated good drainage.


Proforma<br />

Postoperative complications were observed in both the groups. 4 patients out<br />

of 15 in open pyeloplasty group had post op complications (26.66%). Out of 4<br />

patients, 2 patients had wound infection, 1 patient had post-operative fever and 1<br />

patient had post-operative recurrent UTI and 1 patient had post operative fever.<br />

Wound infected patients were treated with appropriate antibiotics after wound culture<br />

and sensitivity. Patient with recurrent UTI was also treated with appropriate<br />

antibiotic after urine culture and sensitivity report. Patient with post operative fever<br />

responded to conservative management. In the laparoscopic pyeloplasty group, 5<br />

patients had post operative complications (33.33%). Prolonged urine leak for more<br />

than 4 days was observed in 2 patients. Post operative paralytic ileus was observed in<br />

2 patients, as the laparoscopic procedure was done by transperitoneal approach. For<br />

these 2 patients, oral feeds were started on 3 rd post operative day. 1 patient had post<br />

operative recurrent UTI, who was treated with appropriate antibiotic after urine<br />

culture and sensitivity report. No patient had significant intra operative or post<br />

operative complications.<br />

In the laparoscopic pyeloplasty group, conversion to open was not done in any<br />

patient. No anastomotic stricture was observed in any patient which was confirmed<br />

by USG or IVP post-operatively. The success rate was 100% in both the groups. The<br />

cost of treatment for laparoscopic pyeloplasty was almost 3 times more than that of<br />

open pyeloplasty. The post-operative scar was almost unnoticeable in case of<br />

laparoscopic pyeloplasty patients (better cosmesis), compared to open pyeloplasty<br />

patients post-operative scar.<br />

The mean operative time was 159±S.D21.3976 minutes in open pyeloplasty<br />

group and 214.6667±S.D32.2638 minutes in laparoscopic pyeloplasty group<br />

(P= 5.874x10 -6 , Student’s unpaired ‘t’ test).


Proforma<br />

The mean time when oral feeds were started in open pyeloplasty group was<br />

1.4667±S.D.0.5164days and 2.33±S.D.0.4880days in laparoscopic pyeloplasty group<br />

(P=5.89x10 -5 , Student’s unpaired ‘t’ test).<br />

The mean time when drain removed was 2.333±S.D.0.4880 days in open<br />

pyeloplasty group and 3.4±S.D.0.6325days in laparoscopic pyeloplasty group<br />

(P=1.73x10 -5 , Student’s unpaired ‘t’ test). The mean hospital stay was<br />

9.0667±S.D2.9633 days and 6.4±S.D.2.8486 days in open and laparoscopic<br />

pyeloplasty group respectively (P=0.018019, Student’s unpaired ‘t’ test). The<br />

average intra-operative blood loss was 150 cc and 60 cc for open pyeloplasty and<br />

laparoscopic pyeloplasty group respectively.<br />

In the literature, only few studies have compared objective and subjective out<br />

comes between open versus laproscopic pyeloplasty. A study conducted by H.<br />

Christoph Klingler et al 58 , compared open versus laparoscopic pyeloplasty techniques<br />

in treatment of UPJ obstruction and the study was conducted between September<br />

1999 to September 2002 Laparoscopic pyeloplasty was done on 40 patients and open<br />

pyeloplasty on 55 patients. The results showed that post-op VAS score was lower in<br />

the laparoscopic group (day 1 3.5 ± 1.6 v/s 5.4 ± 3.1, days 0.9 ± 1.2 v/s 3.1 ± 1.8, P =<br />

0.001) length of skin incision was 4.1 ± 0.7 v/s 23.8 ± 9.1 cms and hospital stay was<br />

5.9 ± 2.1 v/s 13.4 ± 3.8 days for laparoscopic and open pyeloplasty respectively.<br />

Success rate was 96.9% v/s 93.4% for laparoscopic and open pyeloplasty<br />

respectively. 2 patients had abdominal wall herniation and 1 patient had<br />

thromboembolism in open pyeloplasty group.


Proforma<br />

Other study conducted by John. J Bauer and Louis R. Kovoussi 57 compared<br />

laparoscopic v/s open pyeloplasty with respect to objective and subjective outcome.<br />

The results showed that out of 42 laparoscopic group patients, 90% were pain free<br />

and 62% had significant improvement in flank pain 2 patients had minor<br />

improvement and 2 had no improvement in pain, surgery failed in only 1 patient with<br />

complete obstruction. A patent UPJ was demonstrated in 98% of the laparoscopic<br />

group on the most recent radiographic study. Mean follow-up was for 15 months. Of<br />

the 35 open surgery group patients, 91% were pain free, 31% patients significantly<br />

improved after surgery one patient had only minor improvement and 2 were worse.<br />

Another study by D. Duane Baldwin et al 59 , showed single-center comparison<br />

of laparoscopic pyeloplasty, Acucise endopyelotomy and open pyeloplasty. The<br />

study showed success rates of 56%, 94% and 86% for Acucise endopyelotomy,<br />

laparoscopic pyeloplasty and open pyeloplasty respectively. There were no<br />

significant difference between the endopyelotomy and laparoscopic pyeloplasty and<br />

open group in age, ASA score, length of follow-up, blood loss, hospital stay, cost or<br />

analgesic requirement. The laparoscopically treated patient demonstrated lower<br />

analgesic requirements (27.2 v/s 12.42 mg morphine sulfate, P=0.02) and shorter<br />

hospital stay (1.4 v/s 3.0 days P=0.03) than open surgery patient.


SUMMARY AND CONCLUSIONS<br />

Proforma<br />

UPJ is the most common site of upper urinary tract obstruction occurring in 1<br />

in 1500 births and is the most common obstructive uropathy in children. Many<br />

treatment options exist for the management of UPJ obstruction. Open pyeloplasty has<br />

high success rate & has been considered the gold standard with success rate 90-<br />

100%. But there is a significant postoperative pain & long recovery time in open<br />

pyeloplasty surgeries. In an attempt to minimize the postoperative morbidity of open<br />

surgical UPJ correction many minimally invasive options have been developed.<br />

These include balloon dilation, antegrade endopyelotomy, retrograde endopyelotomy,<br />

Acucise endopyelotomy and laparoscopic pyeloplasty. More recently, laparoscopic<br />

procedures to treat UPJO have combined the advantages of minimally invasive<br />

procedures and safety and high success rates obtained with open surgical procedures.<br />

Since the end of the last decade, laparoscopic pyeloplasty has become<br />

increasingly popular. Success rates are quoted to be between 87-100%. The<br />

procedure allows the identification of crossing vessels, excision of the diseased UPJ<br />

plus or minus a reduction pyeloplasty and a watertight anastomosis. In addition, the<br />

analgesic requirement, hospital stay and recovery period are considerably reduced<br />

compared to the open pyeloplasty.<br />

In our present study, we compared prospectively the objective and subjective<br />

outcomes of open and laparoscopic pyeloplasty procedures in the treatment of<br />

primary or congenital UPJ obstruction. Total of 30 patients included in the study<br />

were randomized into two groups of 15 each. 15 patients formed open pyeloplasty<br />

group and other 15 patients formed the laparoscopic pyeloplasty group. The mean


Proforma<br />

age group, laterality of involvement of kidney, sex ratio was almost similar between<br />

both the groups. The pre-operative pain (P=0.69885) and activity (P=0.1524) level<br />

and renal function on renal nucleotide scan (P=0.4621) was almost similar and<br />

comparable between the two groups. But, there was significant post-operative<br />

improvement in pain (P=1.375x10 -8 for open group, P=1.558x10 -13 for laparoscopic<br />

group) and activity level (P=6.156x10 -23 for open group, P=1.626x10 -23 for<br />

laparoscopic group) and improvement in renal function in each group (P=1.048x10 -13<br />

for open group, P=0.0074 for laparoscopic group). In our study we found that,<br />

improvement in pain and activity level post-operatively was much better in<br />

laparoscopic pyeloplasty group patients compared to open pyeloplasty group patients.<br />

But, improvement in renal function on renal scientigraphy which was done at 3<br />

months post-operatively, there was no much difference between both the groups.<br />

Both groups showed significant improvement in renal function and all patients<br />

showed good drainage. There were no major intra-operative complications noted in<br />

either group. Post-operative complications and also time when oral feeds started and<br />

drain removed were slightly more in laparoscopic group owing to transperitoneal<br />

approach. Hospital stay and convalescence period was less in laparoscopic group, but<br />

the mean operative time was more in laparoscopic group (214.6±32.2 minutes)<br />

compared to open pyeloplasty group (159±21.3minutes). There was no conversion to<br />

open procedure done in any of laparoscopic cases. The success rate was 100% in both<br />

the groups. The post-operative cosmesis was better in laparoscopic pyeloplasty<br />

patients compared to open pyeloplasty patients.


The advantages of laparoscopic pyeloplasty procedure are,<br />

Less post-operative morbidity<br />

Short convalescence period<br />

Less post-operative pain<br />

Early recovery of activity.<br />

Success rate almost similar to open pyeloplasty procedure.<br />

Lesser hospital stay.<br />

Better cosmesis.<br />

The disadvantages of laparoscopic pyeloplasty procedure are,<br />

Technically difficult to perform.<br />

Longer operative time.<br />

Proforma<br />

Risk of intra-operative bleeding and conversion to open procedure.<br />

In unskilled hands, the intra and post-operative complications are<br />

more.<br />

Cost of the procedure is more.<br />

Our present study was done on a small number of patients and post-operative<br />

follow up was only for 3 months. It is difficult to draw conclusion from such study.<br />

Hence; large randomized controlled trials with long period of follow up studies are<br />

needed to establish the role of laparoscopic pyeloplasty in the treatment of UPJ<br />

obstruction.


Proforma<br />

The results of laparoscopic pyeloplasty from several institutions reporting on<br />

adult series suggest that this procedure is a viable alternative to both open and<br />

endoscopic procedures with increasing training and experience, the success rate has<br />

clearly exceeded that of endoscopic approaches and is similar to that of open<br />

pyeloplasty. The potential advantages of laparoscopic pyeloplasty over open<br />

pyeloplasty are decreased postoperative pain, shorter hospitalization, short<br />

convalescence and improved cosmesis. An important caveat, as was concluded by<br />

Bauer et al 57 . is that neither open nor laparoscopic pyeloplasty can universally<br />

guarantee complete pain relief.<br />

Laparoscopic pyeloplasty in children is even more technically challenging<br />

than in adults because of the smaller operative space and the need for finer suture<br />

material. However, laparoscopic pyeloplasty has been demonstrated to be feasible<br />

and to have satisfactory early results.<br />

After a decade laparoscopic pyeloplasty has emerged as a durable elective<br />

technique for the management of UPJ obstruction. Laparoscopic pyeloplasty is<br />

continuing to progress and offers promise for some of the most challenging<br />

circumstances. As the technology advances and the clinical experience increases, this<br />

technique may universally replace open pyeloplasty as the gold standard.<br />

Laparoscopic pyeloplasty is a technically challenging procedure and is still in<br />

its infancy and practiced at only few medical centers around the world. With recent<br />

technological advances, laparoscopic pyeloplasty has become a valid alternative to<br />

endoscopic pyelotomy and the gold standard of open pyeloplasty.


BIBLIOGRAPHY<br />

Proforma<br />

1. Single centre comparison of laparoscopic pyeloplasty, Acucise<br />

Endopyelotomy and open pyeloplasty. D. Duane Baldwin, M.D., Jennifer A.<br />

Dunbar, M.D., Nancy Wells, D.N. Sc., R.N., and Elspeth M, Mc Dougall,<br />

M.D., FRCSC. Journal of Endourol vol.17, Nov 3, April 2003.<br />

2. King’s infant children urology. 3 rd edition. P 19-29.Ureteropelvic-junction<br />

obstruction. Hartley G., Cileton JR., and George W. Kaplan.<br />

3. Cambell's urology. Second edition, vol.l. P38-40, 478-489, Vol. 3, 2000-2003,<br />

Management of upper urinary tract obstruction. Steven B. Streem, Jenny J.<br />

Franke & Joseph A. Smith JR.<br />

4. Sankar Kausik, Joseph W.Segura; Surgical management of ureteropelvic<br />

junction obstruction in adults. International Brazil Journal of Urology, vol.29<br />

(1): 3-10, Jan- Feb,2003.<br />

5. Charles M. Mann., Jr., M.D: UPJ obstruction. Pathology of the kidney,<br />

Boston, Little Brown and Co., 1974, p 84.<br />

6. Robson WJ, Rudy SM, Johnston JH: PUJ obstruction in infancy. J of<br />

paediatric surgery.1976:11:57-61.<br />

7. Nixon HH, Hydronephrosis in children. Br J Surg, 1953:40:601-604.<br />

8. Langman J; Urogenital system. Medical embryology, 4th edi. Baltimore,<br />

M.D., Williams and Wilkins, 1981. P234.<br />

9. Flasner SC, King LR; UPJ, In Kelalis PP, King LR, Belman AB (eds),<br />

Clinical pediatric urology. Philadelphia; WB Saunders, 1992, P693.


Proforma<br />

10. Leeson TS, Leeson CR, The urinary system. In histology, Philadelphia; WB<br />

Saunders, 1981, P451.<br />

11. Djurhuss JC, Nerstrom B, Rask-Anderson H; Dynamics of upper urinary tract<br />

in humans. Pre-operative electrophysiologic findings in patients with maifest<br />

or suspected HN. Acta Chir Scand (suppl) 472; 49-58,1976.<br />

12. Ruano Gil D. Coca Payeras A, Tejedo-Mateu A: Obstruction and normal<br />

recanalisation of the ureter in the human embryo: Its relation to congenital<br />

ureteric obstruction. Eur Urol 1975;1:287-293.<br />

13. Hanna MK, Jeffs RD, Sturgess JM, Barkin M: Ureterl structure and ultra<br />

structure: partII, Congenal UPJ obstruction and primary obstructive<br />

megeureter. J Urol 1976; 116:725-730.<br />

14. Seremetis GM, Maizels M; TGF- beta mRNA expression in the renal pelvis<br />

after experimental and clinical UPJ obstruction; J Urol 1996; 150; 261-266.<br />

15. Ostling K: The genesis of hydronephrosis. Acta Chir scand 1942; 86 (suppl) :<br />

72.<br />

16. Stephens FD: Ureterovascular hydronephrosis and the abberent renal vessels.<br />

J Urol 1982 ; 128, 984-987.<br />

17. Lebowitz RL, Blickman JG; The co-existence of UPJ obstruction and reflux.<br />

AJR AmJ Roentgenol 1983;140:231-238.<br />

18. Williams DI, Karlaftis CM: HN due to PUJ obstruction in the new born. Br J<br />

Urol 1960;38:138-144.


Proforma<br />

19. Williams DI, Kenawi MM: The prognosis of PUJ obstruction in childhood: A<br />

review of 190 cases. Eur Urol 1976;2:57-63. Amar AD: Congenital<br />

hydronephrosis of lower segment in duplex kidney. Urology 1976;7;480-485.<br />

20. Mandell J Kinard HW, Mittlestoedt CA, Seeds JW: Prenatal diagnosis of<br />

unilateral HN with early postnatal obstruction. J Urol 132:303-307, 1984.<br />

21. Valayer J, Adda G: HN due to PUJ obstruction in infancy. Br J Urol 54:451-<br />

454,1982.<br />

22. Bryan PJ, Azimi F: Ultrasound in diagnosis of congenital HN due to<br />

obstruction.UPJ Urology.5:17-20,1975.<br />

23. Johnston JE, Evans JP, Glassberg KI: Pelvic HN in children: A review of 219<br />

personal cases. J Urol 117:97-101,1977.<br />

24. Blute ML, Malek RS: Contemporary concepts in diagnosis and management<br />

of UPJ obstruction in adults. A UA update series 1990;Vol.9:lesson 5.<br />

25. Meller ST, Eckstein HB: Renal scientigraphy;Qualitative assessment of upper<br />

urinary tract dilatation in children. J pediatric surg 1981;16:123-126.<br />

26. Merphy L: The hystory of urology. In the Kidney. Springfield IL, Charles C<br />

Thomas ,1972. P197.<br />

27. Cambell's urology. Second edition vol.l.p 479-480, Management of upper<br />

urinary tract obstruction. Steven B. Streem, Jenny J.Franke & Joseph A.Smith<br />

J.R.<br />

28. Notley RG, Beaurgie JM: The long term follows up of Anderson-Hynes<br />

pyeloplasty for HN. Br J Urol 1973; 45:464-467.


Proforma<br />

29. Perksy L, Kraurse JR, Boltuch RL. Initial complications and late results in<br />

dismembered pyeloplasty. J Urol 1977; 118:162-165.<br />

30. Badlani G, Eshghi M, Smith AD: Percutaneous surgery for UPJO<br />

(endopyelotomy): Technique and early results. J Urol 1984; 135:26.<br />

31. Boltom DM, Bogaest GA, Mevorach RA, et al: Pediatric UPJO treated with<br />

retrograde endopyelotomy. Urology 1994; 44:609-613.<br />

32. Garber GS, Lyon ES: Endopyelotomy: Patient selection, results, and<br />

complications. Urology 43:2-10, 1994.<br />

33. Kletscher BA, Segura JW, Le Roy AJ, et al: Percutaneous antegrade<br />

endoscopic pyelotomy: Review of 5 cosecutive cases. J Urol 153:701-<br />

703;1995.<br />

34. Motola JA, Badlani GH, Smith AD: Results of 212 cosecutive<br />

endopyelotomies: An 8 year follow up. J Urol 149: 453-456,1993.<br />

35. Garber GS, Lyon ES: Endopyelotomy: Patient selection, results, and<br />

complications. Urology 43:2-10, 1994.<br />

36. Chandhoke PS, Clayman RV, Stone AM, et al: Endopyelotomy and<br />

Endoureterotomy with Acucise ureteral cutting ballon device; Preliminary<br />

experience. J Endourol 1993b;7:45.<br />

37. Preminger GM, Clayman RV, Nakada SY, et al: A multicentre clinical trial<br />

investigating the use of flouroscopically controlled cutting ballon catheter for<br />

the management of ureteral and UPJ obstruction. J Urol 1997;157:162.


Proforma<br />

38. Lachevallier E, Eghazarian C,Ortega JC, et al: Retrograde<br />

endoureteropyelotomy: Long term results. J Urol 1999;13:575.<br />

39. Biyani CS, Cornford PA, Powel CS: Retrograde endoureteropyelotomy with<br />

the holmium : YAG laser. Initial experience. Eur Urol 1997:32:471.<br />

40. Renner C, Frede T, Seemann O, et al: Laser endopyelotomy: Minimally<br />

invasive therapy of UPJ stenosis. J Endourol 1998:12:537.<br />

41. Tawfiek ER, Liu J, Bagley DH: Ureteroscopic treatment of UPJO: J Urol<br />

1998;160:164.<br />

42. Gerber GS, Kim JC: Ureteroscopic endopyelotomy in the treatment of UPJO.<br />

Urol 2000;55:198.<br />

43. Lettgen B, Meyer-Schwickerath M, Bedow W: Prenatal US diagnosis of the<br />

kidneys and efferent urinary tract. Possibilities applications, and dangers.<br />

Montsschrift Kinder heilkunde 141 : 462-467,1993.<br />

44. Saari-Kappainen A,et al: US screening and perinatal mortality : Controlled<br />

trial of systematic one stage screening in pregnancy. The Helsinki US trial.<br />

Lanset 336:387-391,1990.<br />

45. Mandell J, Peters CA, Retik AB. Current concepts in the perinatal diagnosis<br />

and management of HN. Urol Clinics of North America 17;247,1990.<br />

46. Grignon A, Filion R, Filiatrault D, et al: Urinary tract dilatation in utero.<br />

Classification and clinical approaches. Radiology J 160:645.1986.<br />

47. Duckett JW: When to operate on neonatal HN. Urology 42:617-619,1993.


Proforma<br />

48. Prenatal diagnosis, Therpeutic implications; Pramod P. Reddy, M.D., and<br />

James Mandell, M.D, FACS, FAAP. P 176., The Urologic Clinics Of North<br />

America., May 1998.<br />

49. Nadler, B.R, G.S., Pearle, M.S., Nakada, S.Y and Clayman, R. V. Access’s<br />

endopyelotomy. Assessment of long-term durability J. Urol., 156:1094, 1996.<br />

50. Faerber GJ, Richardson TD, Farah N, et al: Retrograde treatment of UPJO<br />

using the ureteral cutting balloon catheter. J Urol 157; 454-458,1997.<br />

51. Quillin SP, Brink JA,Heiken JP, etal: Helical CT angiography for<br />

identification of crossing vessels at the UPJ. AJR AmJ Roentgenol 166:1125-<br />

1130,1996.<br />

52. Brooks JD, Kouvossi LR, Preminger GM,et al: Comparison of open and<br />

endourologic approaches to the UPJO. Urol 46:791-795:1995.<br />

53. Pattaras JG, and Moore RG: Laparoscopic pyeloplasty. J endourol 14: 895-<br />

904,2000.<br />

54. Moore RG, Averch TD, Schulam PG, et al: Laparoscopic pyeloplasty;<br />

experience with the initial 30 cases. J Urol 157: 459-462,1997.<br />

55. Jarrett TW, Chan DY, Charambura TC, et al: Laparoscopic plyeloplasty: the<br />

first 100 cases. J Urol 167:1253-1256, 2002.<br />

56. Soulie M, Thoulouzan M, Seguin P, Mouly P, Vazzoler N, Plante P:<br />

Retroperitoneal laparoscopic versus open pyeloplasty with a minimal incision.<br />

Comparision of two surgical procedures. Urol 2001; 57:443-447.


Proforma<br />

57. Laparoscopic versus open pyeloplasty: Assessment of objective &<br />

subjective outcome. Journal of Urology, Volume 162(3-1) September<br />

1999 pp 692-695. Bauer JJ, Bishoff JT, Moore RG, Chen RN, Iverson.<br />

58. Comparison of open versus laparoscopic pyeloplasty: Techniques in treatment<br />

of UPJO. H.Christoph Klingler, Mesut Remzi, Guenter Janetschek, Christian<br />

Kratzik, Michael J.Marberger: Euro J Urol 44:340-345,2003.<br />

59. Laparoscopic dismembered pyeloplasty in children: Mallikarjun Reddy, R.B.<br />

Nerli, Rajeev Bashetty and I.R. Ravish., The Journal of Urology, Vol.174,<br />

700-702, Aug 2005.<br />

60. Schuessler, W,W., Grune, M.T., Tecuanhuey, L. V and Preminger, G. M:<br />

Laparoscopic dismembered pyeloplasty. J Urol., 150: 1795, 1993.<br />

61. Laparoscopic Pyeloplasty: History, evolution and future. Ravi Munver, Ernest<br />

RS, Del Pizzo JJ. Journal of Endourology, Vol 18, Number 8, October 2004.


LIST OF ABBREVIATIONS<br />

Proforma<br />

99m –TcDTPA : Technetium labeled Diethylenetriamine - penta-acetic acid.<br />

cm of H2O : Centimeter of water<br />

DRS : Diuretic renal scan<br />

Fr : French unit ( 3 Fr = 1 mm )<br />

GFR / min : Glomerular filtration rate per minute<br />

HN : Hydronephrosis<br />

Hrs : hours<br />

IVP : Intravenous pyelography<br />

Kg : kilogram<br />

MAG-3 : Mercaptoacetyltriglycine.<br />

mCi : milli curie<br />

mg : milligram<br />

min : minute<br />

ml : millilitre<br />

MRI : Magnetic resonance imaging<br />

S.D. : Standard deviation<br />

UPJ : Ureteropelvic junction<br />

UPJO : Ureteropelvic junction obstruction<br />

USG : Ultrasonograghy<br />

UTI : Urinary tract infection<br />

v/s : versus<br />

VCUG : Voiding cystourethrogram<br />

VUR : Vesico-ureteral reflux


Background:<br />

ABSTRACT<br />

Proforma<br />

Ureteropelvic junction obstruction (UPJO) is the most common obstructive<br />

uropathy in children. UPJO can occur in all the age groups. In most cases UPJO is<br />

due to congenital pathology. Open pyeloplasty is considered as gold standard for the<br />

treatment of UPJO. But there is a significant post-operative morbidity. During last<br />

decade, advances in endourological techniques have resulted in significant progress<br />

in the development of minimally invasive surgical procedures to treat UPJ<br />

obstruction. These include balloon dilation, antegrade endopyelotomy, retrograde<br />

endopyelotomy, Acucise endopyelotomy and Laparoscopic pyeloplasty. Since the<br />

end of the last decade, laparoscopic pyeloplasty has become increasingly popular.<br />

Success rates are quoted to be between 87-100%. Only few retrospective studies have<br />

been conducted regarding laparoscopic versus open pyeloplasty. Success rates are<br />

comparable for laparoscopic pyeloplasty and open pyeloplasty.<br />

Aims and objectives of the study:<br />

To compare the efficacy of laparoscopic pyeloplasty versus open pyeloplasty<br />

in the treatment of primary UPJ obstruction with respect to the SUBJECTIVE<br />

OUTCOME (Postoperative pain, activity level, time when oral feeds are started) and<br />

OBJECTIVE OUTCOME (success rate, complications, improvement in renal<br />

function, operative time, recovery time/hospital stay, cost of the treatment and<br />

cosmesis) between laparoscopic and open pyeloplasty.


Materials and methods:<br />

Proforma<br />

Total of 30 patients of congenital UPJO were evaluated and operated. All 30<br />

patients were randomized into two groups of 15 each. One group formed open<br />

pyeloplasty group and other formed laparoscopic pyeloplasty group. All patients<br />

were assessed for objective and subjective outcomes post-operatively and all patients<br />

were followed up for minimum of 3 months. Results were analyzed using Student’s<br />

paired and unpaired ‘t’ tests.<br />

Results:<br />

The mean age group, laterality of involvement of kidney, sex ratio was almost<br />

similar between both the groups. The pre-operative pain (P=0.69885) and activity<br />

(P=0.1524) level and renal function on renal nucleotide scan (P=0.4621) was almost<br />

similar and comparable between the two groups. But, there was significant post-<br />

operative improvement in pain (P=1.375x10 -8 for open group, P=1.558x10 -13 for<br />

laparoscopic group) and activity level (P=6.156x10 -23 for open group, P=1.626x10 -23<br />

for laparoscopic group) and improvement in renal function in each group<br />

(P=1.048x10 -13 for open group, P=0.0074 for laparoscopic group). In our study we<br />

found that, improvement in pain and activity level post-operatively was much better<br />

in laparoscopic pyeloplasty group patients compared to open pyeloplasty group<br />

patients. But, improvement in renal function on renal scientigraphy which was done<br />

at 3 months post-operatively, there was no much difference between both the groups.<br />

Both groups showed significant improvement in renal function and all patients<br />

showed good drainage. There were no major intra-operative complications noted in<br />

either group. Post-operative complications and also time when oral feeds started and<br />

drain removed were slightly more in laparoscopic group owing to transperitoneal


Proforma<br />

approach. Hospital stay and convalescence period was less in laparoscopic group, but<br />

the mean operative time was more in laparoscopic group (214.6±32.2 minutes)<br />

compared to open pyeloplasty group (159±21.3minutes). There was no conversion to<br />

open procedure done in any of laparoscopic cases. The success rate was 100% in both<br />

the groups. The post-operative cosmesis was better in laparoscopic pyeloplasty<br />

patients compared to open pyeloplasty patients.<br />

Conclusions :<br />

Our present study was done on a small number of patients and post-operative<br />

follow up was only for 3 months. It is difficult to draw conclusion from such a study.<br />

Hence; a large randomized controlled trials with long period of follow up studies are<br />

needed to establish the role of laparoscopic pyeloplasty in the treatment of UPJ<br />

obstruction.<br />

The results of laparoscopic pyeloplasty from several institutions reporting on<br />

adult series suggest that this procedure is a viable alternative to both open and<br />

endoscopic procedures with increasing training and experience, the success rate has<br />

clearly exceeded that of endoscopic approaches and is similar to that of open<br />

pyeloplasty. The potential advantages of laparoscopic pyeloplasty over open<br />

pyeloplasty are decreased postoperative pain, shorter hospitalization, short<br />

convalescence and improved cosmesis. Laparoscopic pyeloplasty is a technically<br />

challenging procedure and is still in its infancy and practiced at only few medical<br />

centers around the world. With recent technological advances, laparoscopic<br />

pyeloplasty has become a valid alternative to endoscopic pyelotomy and the gold<br />

standard of open pyeloplasty.


PROFORMA<br />

Name of the patient : I.P.No. :<br />

Age : DOA :<br />

Sex : DOS :<br />

Residence : DOD:<br />

CHIEF COMPLAINTS :<br />

1.<br />

2.<br />

3.<br />

EXAMINATION FINDINGS :<br />

Vitals :<br />

Pulse : BP: mm of Hg RR :<br />

Temp :<br />

Per Abdomen :<br />

INVESTIGATIONS :<br />

1. CBC :<br />

2. Urine Analysis : Routine :<br />

Microscopy :<br />

Proforma<br />

3. Minirenals : RBS : Serun electrolytes :<br />

Blood Urea : Sodium :<br />

Serum creatinine : Potassium :<br />

Cloride :<br />

Bicarbonate :


4. HIV :<br />

HBSAg :<br />

5. X-ray KUB Findings : A.<br />

6. USG abdomen findings : A.<br />

7. IVP findings : A.<br />

8. MR Urogram /99mTc-DTPA scan findings : A.<br />

9. Panendoscopy Report :<br />

10. Chest X-ray :<br />

11. ECG<br />

12. Other investigations :<br />

FINAL DIAGNOSIS :<br />

SURGICAL TREATMENT GIVEN :<br />

INTRA-OPERATIVE FINDINGS :<br />

COMPLICATIONS IF ANY :<br />

B.<br />

C.<br />

B.<br />

C.<br />

B.<br />

C.<br />

B.<br />

C.<br />

Proforma


ASSESSMENT OF OBJECTIVE OUTCOME<br />

Proforma<br />

The analog pain and activity questionnaire assessing pre-operative and<br />

post- operative pain and activity level : (Nadler et al.) 49<br />

1. Please mark on the following scale the level of discomfort you experienced<br />

before your procedure.<br />

0____________________________________________ 100<br />

(No pain) (Worst pain)<br />

2. Please mark on the following scale the level of discomfort you experienced<br />

now, (6 weeks after the procedure)<br />

0 ____________________________________________100<br />

(No pain) (Worst pain)<br />

6. If before your procedure, your discomfort level was 100% what is your<br />

current level of discomfort?<br />

________________________________________________ (0-100%)<br />

7. Please mark on the following scale your level of activity before your<br />

procedure.<br />

0______________________________________________100<br />

(Bed rest) (Full activity)<br />

8. Please mark on the following scale your level of activity after the<br />

procedure (6 weeks).<br />

0______________________________________________100<br />

(Bed rest) (Full activity)


ASSESSMENT OF OBJECTIVE OUTCOME<br />

a. Operative time (in minutes) :<br />

b. Hospital stay (No. of days) :<br />

c. Time when oral feeds started :<br />

d. Time when drain removed :<br />

e. Post-operative 99m-Tc DTPA scan findings after 3 months :<br />

f. Antibiotics / Analgesics given :<br />

g. Cosmesis :<br />

h. Cost of treatment :<br />

i. Others :<br />

Proforma


52<br />

SELECTED PUBLISHED EXPERIENCE WITH LAPAROSCOPIC PYELOPLASTY 61<br />

Source<br />

No. of<br />

Cases<br />

Operative<br />

time (Min)<br />

Hospital<br />

stay (days)<br />

Technique Approach<br />

Open<br />

conversions<br />

rate (%)<br />

Success<br />

Rate (%)<br />

Schuessler et al. 1993 5 210-420 3 Dismembered Transperitoneal 0 100<br />

Kavoussi et al. 1993 1 480 3 Dismembered Transperitoneal 0 100<br />

Recker et al. 1995 5 190-390 8 Dismembered Transperitoneal 20 100<br />

Nakada et al. 1995 4 465-645 4 Dismembered Culp-De<br />

Weerd<br />

Transperitoneal 0 100<br />

Janetschek et al. 1996 16 240-360 5.1 Dismembered Transperitoneal 0 100<br />

Puppo et al. 1997 11 150-240 3.3 Dismembered Retroperitoneal 0 100<br />

Moore et al. 1997 30 135-480 3.5 (Dismembered Y-V Plasty Transperitoneal 0 97<br />

Eden et al. 1997 9 150-230 3 Dismembered Retroperitoneal 11 100<br />

Chess et al. 1998 57 138-480 3.3 DismemberedY-V Plasty Transperitoneal 0 97<br />

Bauer et al. 1999 42 - - Dismembered Y-V Plasty Transperitoneal 0 98<br />

Janetschek et al. 2000 67 90-120 4.1 Fenger (63) Y-V (4) Trans & Retro<br />

peritoneal<br />

0 98<br />

Ben Slama et al. 2000 15 100-250 4.8 Dismembered (7) Fenger<br />

(7)<br />

Retroperitoneal 7 100<br />

Soulie et al. 2001 55 100-260 4.5 Dismembered (48) Fenger Retroperitoneal 5 88<br />

Eden et al. 2001 50 120-240 2.6 Dismembered Retroperitoneal 4 98<br />

Turk et al. 2002 49 90-240 3.7 Dismembered Transperitoneal 0 98<br />

Jarnett et al. 2002 100 120-480 3.3 Dismembered Heineke –<br />

Mekulicz<br />

Transperitoneal 0 96<br />

Review of


91<br />

1.Pain<br />

PREOPERATIVE AND POSTOPERATIVE PYELOPLASTY ANALOG PAIN AND ACTIVITY SCORES<br />

Parameter<br />

-Preoperative 61.3333<br />

Open pyeloplasty group<br />

(n=15)<br />

Laparoscopic<br />

pyeloplasty group<br />

(n=15)<br />

Mean ± S.D Mean ± S.D<br />

(0-100)<br />

18.0739 59.00<br />

(0-100)<br />

Student’s<br />

unpaired `t’<br />

test<br />

P value<br />

14.4173 0.69885(NS)<br />

-Postoperative 18.0(0-100) 12.6491 5.33(0-100) 7.43223 0.00235989 1.375x10 -8 (HS)<br />

-Difference -43.333 -53.67<br />

2.Activity<br />

-Preoperative 54.66(0-100) 9.9043 48.66(0-100) 3.5187 0.1524(NS)<br />

Student’s paired ‘t’ test<br />

P value<br />

Open group Lap group<br />

1.55847x10 -13 (HS)<br />

-Postoperative 90.66(0-100) 7.9881 96.33(0-100) 4.8058 0.02580719(S) 6.156x10 -23 (HS) 1.6167x10 -23 (HS)<br />

-Difference 40.00 47.67<br />

3.GFR/min on renal scan<br />

-Preoperative 34.6000 27.3673 29.2667 4.3337 0.4621965(NS)<br />

-Postoperative 53.2000 4.6012 52.800 5.4929 0.8303954(NS) 1.048x10 -13 (HS) 0.0074303(VS)<br />

-Difference -18.600 -23.53<br />

Observati o n s &

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!